aldosterone has been researched along with Chronic Kidney Failure in 351 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Blood pressure, heart rate, concentrations of aldosterone, urea, creatinine, electrolytes, and protein, index of hypertrophy of visceral organs, and 24-h diuresis were evaluated." | 7.74 | Effect of spironolactone on hypertrophy of left ventricular myocardium in wistar rats with experimental uremia. ( Beresneva, ON; Esaian, AM; Karabayeva, AZh; Kayukov, IG; Kotenko, LV; Parastaeva, MM; Sevastyanova, IE, 2008) |
| " Here, we examined the effects of the ANG II receptor type 1 (AT1R) blockade using candesartan on long-term renal molecular and functional changes in response to partial unilateral ureteral obstruction (PUUO)." | 7.74 | Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. ( Djurhuus, JC; Frøkiaer, J; Jørgensen, TM; Knepper, M; Nielsen, S; Nørregaard, R; Pedersen, M; Topcu, SO; Wang, G, 2007) |
| "To assess the mechanism involved in hyperkalemia during angiotensin converting enzyme inhibition with captopril in chronic renal failure, captopril, 150 mg/day, was administered to 16 patients with hypertension with plasma creatinine levels between 1." | 7.67 | Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure. ( Ajzen, H; Draibe, SA; Kater, CE; Mattei, E; Zanella, MT, 1985) |
| "In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)." | 6.65 | [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984) |
| "In addition, insulin resistance is not limited to classic insulin-sensitive tissues such as skeletal muscle, but it also affects the cardiovascular system, where it participates in the development of CVD and CKD." | 6.46 | Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. ( Dhuper, S; Johnson, MS; Lastra, G; Sowers, JR, 2010) |
| "Aldosterone levels were associated with cardiac hypertrophy and carotid artery stenosis." | 5.48 | Aldosterone and Insulin Resistance: Vicious Combination in Patients on Maintenance Hemodialysis. ( Inamoto, H; Itoh, H; Kawashima, S; Minakuchi, H; Minakuchi, J; Miya, K; Tada, H; Takamatsu, N; Tani, E; Wakino, S, 2018) |
| "Metabolic syndrome is an important risk factor for proteinuria and chronic kidney disease independent of diabetes and hypertension; however, the underlying mechanisms have not been elucidated." | 5.33 | Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. ( Ando, K; Fujita, T; Gotoda, T; Nagase, M; Nagase, T; Shibata, S; Yoshida, S, 2006) |
| "From these data it emerges that hyperaldosteronism, as observed in these patients with CRI, is a relatively reliable marker of the extent of CRI and may occur independently of the activation of the RAA system, given that other factors, such as orthostatic stimulation, alterations in the acid-base equilibrium, and the degree of aldosterone hepatic and urinary clearance, contribute to its pathogenesis." | 5.29 | [Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency]. ( Buracchi, P; Carletti, F; Gennari, C; Lucani, B; Martinelli, M; Nami, R; Panza, F; Pavese, G; Saia, F, 1993) |
| "In primary aldosteronism, high UA and PAC together with suppressed PRA represent an important diagnostic guideline for differentiation from other types of low-renin hypertensions." | 5.26 | Renin-angiotensin-aldosterone system in arterial hypertension. ( Gregorová, I; Horký, K, 1980) |
| "Add-on losartan therapy did not improve proteinuria or ABP over one month of add on therapy." | 5.09 | Add-on angiotensin receptor blockade with maximized ACE inhibition. ( Agarwal, R, 2001) |
| "To investigate the pathogenetic constellation and its modification by calcium channel blockade in hypertension associated with chronic nonoliguric renal failure, blood pressure (BP), various pressor factors or correlates, cardiovascular responsiveness, and plasma atrial natriuretic peptide (ANP) were assessed in 15 hypertensive patients (serum creatinine 160-715 mumol/l) before and after 6 weeks of intervention with the agent nitrendipine." | 5.06 | Hypertensive dysregulation and its modification by calcium channel blockade in nonoliguric renal failure. ( Bürgisser, E; Ferrier, C; Gnädinger, MP; Jahn, H; Schohn, D; Weidmann, P, 1989) |
| " Blood pressure, heart rate, concentrations of aldosterone, urea, creatinine, electrolytes, and protein, index of hypertrophy of visceral organs, and 24-h diuresis were evaluated." | 3.74 | Effect of spironolactone on hypertrophy of left ventricular myocardium in wistar rats with experimental uremia. ( Beresneva, ON; Esaian, AM; Karabayeva, AZh; Kayukov, IG; Kotenko, LV; Parastaeva, MM; Sevastyanova, IE, 2008) |
| " Here, we examined the effects of the ANG II receptor type 1 (AT1R) blockade using candesartan on long-term renal molecular and functional changes in response to partial unilateral ureteral obstruction (PUUO)." | 3.74 | Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. ( Djurhuus, JC; Frøkiaer, J; Jørgensen, TM; Knepper, M; Nielsen, S; Nørregaard, R; Pedersen, M; Topcu, SO; Wang, G, 2007) |
| " Two groups of elderly hemodialysis patients were evaluated to determine if excessive interdialytic weight gain was related to differences in postdialysis plasma osmolality or postdialysis measurement of plasma renin activity, or plasma levels of angiotensin II (a dipsogenic hormone), aldosterone, and vasopressin." | 3.69 | Evaluation of plasma osmolality and hormone responses in elderly chronic hemodialysis patients with excessive interdialytic weight gain. ( Chan, R; Michelis, MF; Samuel-Variath, R, 1997) |
| "In twelve hypertensive patients with end-stage renal disease (ESRD) due to chronic glomerulonephritis (CGN), the mechanisms of renin and aldosterone regulation were studied by exogenously infused angiotensin II, captopril, and upright posture." | 3.69 | The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis. ( Ishii, M; Nagasawa, T; Shionoiri, H; Umemura, S; Yasuda, G, 1994) |
| "To assess the mechanism involved in hyperkalemia during angiotensin converting enzyme inhibition with captopril in chronic renal failure, captopril, 150 mg/day, was administered to 16 patients with hypertension with plasma creatinine levels between 1." | 3.67 | Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure. ( Ajzen, H; Draibe, SA; Kater, CE; Mattei, E; Zanella, MT, 1985) |
| "We examined renal function and Na+ balance in a patient with congestive heart failure who was treated with demeclocycline (DMC) on three separate occasions under strict metabolic balance conditions." | 3.67 | Demeclocycline-induced natriuresis and renal insufficiency: in vivo and in vitro studies. ( Braden, GL; Cox, M; Geheb, MA; Shook, A; Singer, I, 1985) |
| "Eleven patients with hypertension secondary to renal disease were treated with hydrochlorothiazide or furosemide plus other drugs to normalize blood pressure." | 3.66 | Use of diuretics in treatment of hypertension secondary to renal disease. ( Bank, N; Lief, PD; Piczon, O, 1978) |
| "Antihypertensive effect of an orally active angiotensin I-Converting enzyme inhibitor, SQ 14225 (Captopril) was assessed in 18 hypertensive patients, of whom 13 had essential hypertension, 2 had malignant hypertension, 2 had hypertension associated with chronic renal failure, and 1 had renovascular hypertension." | 3.66 | Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients. ( Fukuchi, S; Gotoh, M; Matsui, J; Mizuno, K, 1981) |
| "The effect of saralasin in lowering blood pressure and plasma aldosterone concentration in normal subjects, both sodium-replete and sodium-deplete, and in patients with various forms of hypertension, is closely related to the basal plasma angiotensin II concentration." | 3.65 | The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration. ( Brown, JJ; Brown, WC; Fraser, R; Lever, AF; Morton, JJ; Robertson, JI; Rosei, EA; Trust, PM, 1976) |
| "Gynecomastia was rare and did not differ significantly between groups." | 2.90 | Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial. ( Anderson, AH; Charytan, DM; Dember, LM; DiCarli, M; Himmelfarb, J; Hsu, JY; Hung, AM; Ikizler, TA; Kimmel, PL; Kliger, AS; Landis, JR; Mehrotra, R; Raj, DS; Sharma, S; Skali, H; Weiner, DE; Williams, M, 2019) |
| "Aldosterone has emerged as an important mediator of disease progression and mortality in patients with chronic heart and kidney disease (CKD)." | 2.75 | The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease. ( Edwards, NC; Ferro, CJ; Hammer, F; Hughes, BA; Steeds, RP; Stewart, PM; Townend, JN, 2010) |
| "Hyperkalemia is a common life-threatening problem in hemodialysis patients." | 2.74 | Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients. ( Dick, B; Farese, S; Frey, BM; Frey, FJ; Kruse, A; Pasch, A; Uehlinger, DE, 2009) |
| "Aldosterone and renin were measured at the beginning and end of the study." | 2.71 | Is spironolactone safe for dialysis patients? ( Biederman, RW; Dreyfus, DE; Hussain, S; Marcus, RJ; McGill, RL, 2003) |
| " However, since haemodialysis patients are prone to hyperkalaemia, a known side effect of spironolactone, this treatment is not used in this population." | 2.71 | Safety of low-dose spironolactone administration in chronic haemodialysis patients. ( Fumeaux, Z; Mach, F; Martin, PY; Perneger, T; Rossier, M; Saudan, P; Schnetzler, B; Stoermann, C, 2003) |
| "Treatment with spironolactone in HD patients reduced alpha subunit mRNA expression to values similar to those of normal subjects." | 2.71 | Effect of spironolactone on K(+) homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients. ( González, M; Marusic, ET; Michea, L; Vukusich, A; Zehnder, C, 2004) |
| " Fifteen patients on hemodialysis receiving FCA with its dosage gradually increased from 0 to 0." | 2.70 | Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis. ( Furuya, R; Hishida, A; Kumagai, H; Maruyama, Y; Sakao, T, 2002) |
| "Hypertension is commonly associated with chronic renal disease in cats, and inappropriate activation of the renin-angiotensin-aldosterone system (RAAS) may contribute to the hypertensive state." | 2.70 | Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease. ( Henik, RA; Steele, JL; Stepien, RL, 2002) |
| "Losartan is a selective angiotensin AT1 receptor antagonist currently employed in the management of essential hypertension." | 2.69 | Pharmacokinetics and blood pressure response of losartan in end-stage renal disease. ( Gehr, TW; Halstenson, CE; Keane, WF; Sica, DA, 2000) |
| "Propranolol and enalapril were ineffective antihypertensive agents in most cats of this study." | 2.68 | Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. ( Armstrong, J; Brownfield, M; Henik, RA; Jensen, J, 1997) |
| "The effects of 2 days of oral dosing with sulindac (200 mg twice a day) or indomethacin (75 mg twice a day) on glomerular filtration rate, urinary excretion of prostaglandin E2, sodium homeostasis, and other renal function parameters were investigated in eight patients with chronic stable impaired renal function." | 2.66 | Acute renal effects of sulindac and indomethacin in chronic renal failure. ( Berg, KJ; Talseth, T, 1985) |
| "In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)." | 2.65 | [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984) |
| " The results obtained from single-blind, placebo-controlled studies indicate that indapamide is a safe and effective agent to use in lowering the blood pressure of hypertensive patients with normal renal function, those with various degrees of renal impairment, and those who are undergoing long-term maintenance hemodialysis." | 2.65 | Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment. ( Acchiardo, SR; Skoutakis, VA, 1983) |
| " The efficacy of MMF as an immunosuppressant and long-term safety in cats of this dosage regimen is unknown." | 2.61 | ( Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z, 2019) |
| "The progression to ESRD in patients with obesity and diabetes continues despite widespread use of inhibitors of the renin-angiotensin-aldosterone system (RAAS) along with aggressive blood pressure and glycemic control in these high-risk populations." | 2.55 | Obesity and kidney disease: from population to basic science and the search for new therapeutic targets. ( Sowers, JR; Whaley-Connell, A, 2017) |
| "Aldosterone has also been shown to increase blood pressure by a direct activation of the sympathetic nervous system, to cause endothelial and vascular smooth muscle cell dysfunction, myocardial remodeling and fibrosis, and to have pro-arrhythmogenic actions in the heart." | 2.55 | Mineralocorticoid Receptor Blockade in End-Stage Renal Disease. ( Gosmanova, EO; Lyubarova, R, 2017) |
| "19." | 2.53 | Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety. ( Bomback, AS, 2016) |
| "Aldosterone has a number of non-classical, mineralocorticoid receptor (MR)-mediated actions, including tissue remodeling, modulation of vascular tone and stimulating inflammation and fibrosis, which may fuel progression of end organ damage." | 2.47 | Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage. ( Bakker, SJ; de Vries, LV; Hillebrands, JL; Laverman, GD; Navis, G; van Goor, H; Waanders, F, 2011) |
| "Aldosterone antagonists have been highly successful in treating congestive heart failure and resistant hypertension." | 2.47 | Mineralocorticoid receptor blockade in chronic kidney disease. ( Bomback, AS; Klemmer, PJ; Volk, MJ, 2011) |
| "In addition, insulin resistance is not limited to classic insulin-sensitive tissues such as skeletal muscle, but it also affects the cardiovascular system, where it participates in the development of CVD and CKD." | 2.46 | Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. ( Dhuper, S; Johnson, MS; Lastra, G; Sowers, JR, 2010) |
| "End-stage renal disease (ESRD) comprises an enormous public health burden, with an incidence and prevalence that are increasingly on the rise." | 2.41 | Aldosterone as a mediator of progressive renal dysfunction: evolving perspectives. ( Epstein, M, 2001) |
| "Hyperkalemia is a common feature of chronic renal insufficiency, usually ascribed to impaired K+ homeostasis." | 2.41 | Hyperkalemia: An adaptive response in chronic renal insufficiency. ( Gennari, FJ; Segal, AS, 2002) |
| "Conditions of secondary aldosteronism are common in clinical medicine, occurring in normotensive and hypertensive settings." | 2.39 | Secondary aldosteronism. ( Corry, DB; Tuck, ML, 1995) |
| " Both acutely and chronically in patients with essential hypertension, enalapril reduced blood pressure with a rather flat dose-response curve." | 2.37 | An overview of the clinical pharmacology of enalapril. ( Davies, RO; Gomez, HJ; Irvin, JD; Walker, JF, 1984) |
| "The mechanism of metabolic acidosis in chronic renal failure including metabolic acidosis in children undergoing dialysis and in recipients of kidney transplantation, and its relationships to mineral and electrolyte metabolism have been presented." | 2.36 | Acid-base disorders and the kidney. ( Chan, JC, 1983) |
| "While progressive chronic renal failure (CRF) does not seem to significantly after the secretion or metabolism of cortisol it is possible that CRF causes a state of chronic hyperaldosteronism that is essential to maintain normal excretion (secretion) of potassium per nephron as renal mass progressively decreases." | 2.35 | Kidney and adrenocortical hormones. ( Better, O; Kleeman, CR; Levi, J, 1975) |
| "In patients with CKD, untreated chronic metabolic acidosis often leads to an accelerated reduction in GFR." | 1.56 | Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease. ( Bushinsky, DA; Buysse, JM; Wesson, DE, 2020) |
| "Aldosterone levels were associated with cardiac hypertrophy and carotid artery stenosis." | 1.48 | Aldosterone and Insulin Resistance: Vicious Combination in Patients on Maintenance Hemodialysis. ( Inamoto, H; Itoh, H; Kawashima, S; Minakuchi, H; Minakuchi, J; Miya, K; Tada, H; Takamatsu, N; Tani, E; Wakino, S, 2018) |
| "Aldosterone is an inverse predictor of mortality and CV events in ESRD patients." | 1.42 | Aldosterone, mortality, cardiovascular events and reverse epidemiology in end stage renal disease. ( Abd ElHafeez, S; Mallamaci, F; Tripepi, G; Zoccali, C, 2015) |
| "Fifteen ESRDh achieved steroid responses not different than healthy volunteers; four had primary adrenal insufficiency; six had secondary adrenal insufficiency; nine had selective hypoaldosteronism and sixteen secondary hyperaldosteronism." | 1.40 | Adrenocortical function in hypotensive patients with end stage renal disease. ( Aguirre, EC; Arregger, AL; Cardoso, EM; Contreras, LN; Elbert, A; Zucchini, A, 2014) |
| "Aldosterone was associated with congestive heart failure (adjusted hazard ratio, 1." | 1.40 | Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. ( Bansal, N; Deo, R; Feldman, HI; Keane, MG; Khan, AM; Leonard, MB; Shlipak, MG; Soliman, EZ; Steigerwalt, S; Townsend, RR; Yang, W; Zhang, X, 2014) |
| "Twenty-nine ESRD patients with sustained hypotension were investigated for possible AI." | 1.35 | Diagnostic value of salivary cortisol in end stage renal disease. ( Arregger, AL; Cardoso, EM; Contreras, LN; Tumilasci, O, 2008) |
| "Metabolic syndrome is an important risk factor for proteinuria and chronic kidney disease independent of diabetes and hypertension; however, the underlying mechanisms have not been elucidated." | 1.33 | Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. ( Ando, K; Fujita, T; Gotoda, T; Nagase, M; Nagase, T; Shibata, S; Yoshida, S, 2006) |
| "In early chronic renal failure after 5/6 nephrectomy adrenal aldosterone production is elevated despite a marked decrease of plasma renin activity." | 1.32 | Adrenal aldosterone biosynthesis is elevated in a model of chronic renal failure--role of local adrenal renin-angiotensin system. ( Boeger, CA; Endemann, DH; Krämer, BK; Riegger, GA; Wolf, K, 2004) |
| "The syndrome is characterised by sodium retention and hypervolemia despite low plasma renin activity and aldosterone levels." | 1.30 | [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency]. ( Caillette, A; Corvol, P; Fiet, J; Krozowski, Z; Marc, JM; Morineau, G; Pascoe, L, 1997) |
| "From these data it emerges that hyperaldosteronism, as observed in these patients with CRI, is a relatively reliable marker of the extent of CRI and may occur independently of the activation of the RAA system, given that other factors, such as orthostatic stimulation, alterations in the acid-base equilibrium, and the degree of aldosterone hepatic and urinary clearance, contribute to its pathogenesis." | 1.29 | [Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency]. ( Buracchi, P; Carletti, F; Gennari, C; Lucani, B; Martinelli, M; Nami, R; Panza, F; Pavese, G; Saia, F, 1993) |
| "Hypotension is a frequent complication in patients subjected to regular hemodialysis." | 1.29 | Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients. ( Gladziwa, U; Heintz, B; Kirsten, R; Mann, H; Nelson, K; Reiners, K; Riehl, J; Sieberth, HG; Wieland, D, 1993) |
| "SACE levels in patients with chronic renal failure and on haemodialysis (17." | 1.29 | Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis. ( Cerci, S; Cinotti, GA; D'Ambrosio, C; De Ciocchis, A; Letizia, C; Mazzaferro, S; Morabito, S; Scavo, D, 1995) |
| "Furthermore, plasma from patients with chronic renal failure contains a polar substance(s) that cross-reacts with antialdosterone antibodies." | 1.28 | Falsely elevated plasma aldosterone concentration by direct radioimmunoassay in chronic renal failure. ( Koshida, H; Miyamori, I; Miyazaki, R; Takeda, R; Tofuku, Y, 1989) |
| "Subjects with ESRD had a progressive increase in plasma potassium, in contrast to normal subjects who exhibited a characteristic diurnal variation." | 1.28 | Diltiazem enhances potassium disposal in subjects with end-stage renal disease. ( Dubey, A; Solomon, R, 1992) |
| " Dosage reductions may not be necessary in the majority of dialysis patients." | 1.28 | Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients. ( Davis, J; Duchin, KL; Fakhry, I; Gehr, TW; Grasela, DM; Sica, DA, 1991) |
| "Further volume expansion in liver cirrhosis by saline infusion led to the further increase in ANP (13." | 1.27 | Radioimmunoassay of atrial natriuretic peptide in human plasma: application to studies of volume and blood pressure homeostasis. ( Horký, K; Lachmanová, J; Srámková, J; Tesar, V; Widimský, J, 1988) |
| " Renal impairment had no effect on plasma captopril Cmax, CLtot and relative bioavailability (AUC)." | 1.27 | Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients. ( Chaignon, M; Giroux, B; Giudicelli, JF; Guedon, J; Richer, C, 1984) |
| "Hyperkalemia has been implicated in the pathogenesis of metabolic acidosis in chronic renal insufficiency because acidosis is ameliorated after administration of medications that correct hyperkalemia: mineralocorticoids, diuretics, intestinal K+-binding agents." | 1.27 | Amelioration of metabolic acidosis by dietary potassium restriction in hyperkalemic patients with chronic renal insufficiency. ( Hulter, HN; Jones, JW; Kurtz, I; Maher, T; Schambelan, M; Sebastian, A, 1984) |
| " In patients with severe renal failure, adjustment of the dose or the dosing frequency to the degree of renal failure is recommended to avoid administration of doses in excess of those required to achieve adequate inhibition of converting enzyme." | 1.27 | Lisinopril in hypertensive patients with and without renal failure. ( Boer, P; Geyskes, GG; van Schaik, BA, 1987) |
| "Because hyponatremia is frequently associated with preceding diuretic treatment and unrestricted fluid intake--conditions which have not been addressed sufficiently in published literature--we studied the pathophysiology and the clinical setting of such hyponatremia in a large group of internal medicine patients." | 1.27 | Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients. ( Gross, P; Hackenthal, E; Hausmann, C; Ketteler, M; Rascher, W; Reinhard, C; Ritz, E; Schömig, A, 1988) |
| "Eight patients with chronic renal failure before the stage of dialysis (Group 1), 11 patients on regular dialysis treatment (Group 2) and 14 healthy control subjects (Group 3) were studied before, during and after angiotensin II (AII)-infusion." | 1.27 | Reduced angiotensin II induced vascular reactivity in chronic renal failure. ( Christensen, NJ; Danielsen, H; Jespersen, B; Pedersen, EB; Sørensen, SS, 1988) |
| "In the hyperkalemic chronic renal failure patients, however, metoclopramide failed to induce a significant increase in plasma aldosterone (peak aldosterone 13 +/- 3 ng/dl or 360 +/- 83 pmol/l)." | 1.27 | Effect of dopaminergic blockade on plasma aldosterone in acquired hypoaldosteronism. ( Chusid, P; Hoeldtke, RD; Krishna, GG, 1987) |
| " After renal transplantation a lack of night-day variation in renin secretion was observed in both patients; only one of the two patients showed episodic secretion of PA while PC was suppressed in both patients probably due to the chronic administration of prednisone." | 1.26 | Control of plasma aldosterone in terminal renal failure before and after nephrectomy and after renal transplantation. ( Armbruster, H; Beckerhoff, R; Furrer, J; Siegenthaler, W; Uhlschmid, G; Vetter, W; Záruba, K, 1976) |
| "Plasma aldosterone in the primary aldosteronism group increased significantly at 0." | 1.26 | Effects of angiotensin III and ACTH on aldosterone secretion. ( Luetscher, JA; Zager, PG, 1982) |
| "In primary aldosteronism, high UA and PAC together with suppressed PRA represent an important diagnostic guideline for differentiation from other types of low-renin hypertensions." | 1.26 | Renin-angiotensin-aldosterone system in arterial hypertension. ( Gregorová, I; Horký, K, 1980) |
| " In normal subjects, Sar1-Ile-AII showed pressor (agonistic) activity, which was related to both dosage and sodium intake." | 1.26 | Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders. ( Doi, K; Hata, T; Ichihara, K; Kumahara, Y; Ogihara, T; Yamamoto, T, 1976) |
| "In 5 patients with polycystic kidney disease and creatinine clearances ranging from 4 to 40 ml/min, relationships between changes in blood pressure, sodium balance, body fluid compartments, plasma renin activity (PRA), urinary aldosterone excretion, and plasma aldosterone concentrations were studied during periods of low, medium, and high sodium intake." | 1.25 | Relationships of the renin-angiotensin-aldosterone system and sodium balance to blood pressure regulation in chronic renal failure of polycystic kidney disease. ( Galla, SJ; Leenen, FH; McDonald, RH; Redmond, DP; Shapiro, AP; Vagnucci, AH, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 206 (58.69) | 18.7374 |
| 1990's | 47 (13.39) | 18.2507 |
| 2000's | 50 (14.25) | 29.6817 |
| 2010's | 44 (12.54) | 24.3611 |
| 2020's | 4 (1.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, J | 1 |
| Yun, KS | 1 |
| Cho, A | 1 |
| Kim, DH | 1 |
| Lee, YK | 1 |
| Choi, MJ | 1 |
| Kim, SH | 1 |
| Kim, H | 1 |
| Yoon, JW | 1 |
| Park, HC | 1 |
| Mende, CW | 1 |
| Samarakoon, R | 1 |
| Higgins, PJ | 1 |
| Bobenko, AI | 1 |
| Heller, S | 1 |
| Schmitt, N | 1 |
| Cherdtrakulkiat, R | 1 |
| Lawung, R | 1 |
| Nabu, S | 1 |
| Tantimavanich, S | 1 |
| Sinthupoom, N | 1 |
| Prachayasittikul, S | 1 |
| Prachayasittikul, V | 1 |
| Zhang, B | 1 |
| Wu, C | 1 |
| Zhang, Z | 2 |
| Yan, K | 1 |
| Li, C | 2 |
| Li, Y | 4 |
| Li, L | 3 |
| Zheng, C | 1 |
| Xiao, Y | 1 |
| He, D | 1 |
| Zhao, F | 1 |
| Su, JF | 1 |
| Lun, SM | 1 |
| Hou, YJ | 1 |
| Duan, LJ | 1 |
| Wang, NC | 1 |
| Shen, FF | 1 |
| Zhang, YW | 1 |
| Gao, ZW | 1 |
| Li, J | 5 |
| Du, XJ | 1 |
| Zhou, FY | 1 |
| Yin, Z | 1 |
| Zhu, J | 2 |
| Yan, D | 1 |
| Lou, H | 1 |
| Yu, H | 1 |
| Feng, C | 1 |
| Wang, Z | 1 |
| Wang, Y | 4 |
| Hu, X | 1 |
| Li, Z | 2 |
| Shen, Y | 1 |
| Hu, D | 1 |
| Chen, H | 1 |
| Wu, X | 1 |
| Duan, Y | 1 |
| Zhi, D | 1 |
| Zou, M | 2 |
| Zhao, Z | 1 |
| Zhang, X | 3 |
| Yang, X | 2 |
| Zhang, J | 2 |
| Wang, H | 1 |
| Popović, KJ | 1 |
| Popović, DJ | 1 |
| Miljković, D | 1 |
| Lalošević, D | 1 |
| Čapo, I | 1 |
| Popović, JK | 1 |
| Liu, M | 1 |
| Song, H | 2 |
| Xing, Z | 1 |
| Lu, G | 1 |
| Chen, D | 1 |
| Valentini, AM | 1 |
| Di Pinto, F | 1 |
| Coletta, S | 1 |
| Guerra, V | 1 |
| Armentano, R | 1 |
| Caruso, ML | 1 |
| Gong, J | 1 |
| Wang, N | 1 |
| Bian, L | 1 |
| Wang, M | 1 |
| Ye, M | 1 |
| Wen, N | 1 |
| Fu, M | 1 |
| Fan, W | 1 |
| Meng, Y | 1 |
| Dong, G | 1 |
| Lin, XH | 1 |
| Liu, HH | 1 |
| Gao, DM | 1 |
| Cui, JF | 1 |
| Ren, ZG | 1 |
| Chen, RX | 1 |
| Önal, B | 1 |
| Özen, D | 1 |
| Demir, B | 1 |
| Akkan, AG | 1 |
| Özyazgan, S | 1 |
| Payette, G | 1 |
| Geoffroy, V | 1 |
| Martineau, C | 1 |
| Villemur, R | 1 |
| Jameel, T | 1 |
| Baig, M | 1 |
| Gazzaz, ZJ | 1 |
| Tashkandi, JM | 1 |
| Al Alhareth, NS | 1 |
| Khan, SA | 1 |
| Butt, NS | 1 |
| Wang, J | 2 |
| Geng, Y | 1 |
| Zhang, Y | 3 |
| Wang, X | 2 |
| Liu, J | 2 |
| Basit, A | 1 |
| Miao, T | 1 |
| Liu, W | 1 |
| Jiang, W | 1 |
| Yu, ZY | 1 |
| Wu, L | 2 |
| Qu, B | 1 |
| Sun, JX | 1 |
| Cai, AL | 1 |
| Xie, LM | 1 |
| Groeneveld, J | 1 |
| Ho, SL | 1 |
| Mackensen, A | 1 |
| Mohtadi, M | 1 |
| Laepple, T | 1 |
| Genovesi, S | 1 |
| Nava, E | 1 |
| Bartolucci, C | 1 |
| Severi, S | 1 |
| Vincenti, A | 1 |
| Contaldo, G | 1 |
| Bigatti, G | 1 |
| Ciurlino, D | 1 |
| Bertoli, SV | 1 |
| Slovak, JE | 1 |
| Hwang, JK | 1 |
| Rivera, SM | 1 |
| Villarino, NF | 1 |
| Li, S | 1 |
| Cao, G | 1 |
| Ling, M | 1 |
| Ji, J | 1 |
| Zhao, D | 1 |
| Sha, Y | 1 |
| Gao, X | 1 |
| Liang, C | 2 |
| Guo, Q | 1 |
| Zhou, C | 1 |
| Ma, Z | 1 |
| Xu, J | 1 |
| Wang, C | 1 |
| Zhao, W | 1 |
| Xia, X | 1 |
| Jiang, Y | 1 |
| Peng, J | 1 |
| Jia, Z | 1 |
| Li, F | 1 |
| Chen, X | 2 |
| Mo, J | 1 |
| Zhang, S | 2 |
| Li, X | 1 |
| Huang, T | 1 |
| Zhu, Q | 1 |
| Wang, S | 1 |
| Ge, RS | 1 |
| Fortunato, G | 1 |
| Lin, J | 2 |
| Agarwal, PK | 1 |
| Kohen, A | 1 |
| Singh, P | 1 |
| Cheatum, CM | 1 |
| Zhu, D | 1 |
| Hayman, A | 1 |
| Kebede, B | 1 |
| Stewart, I | 1 |
| Chen, G | 1 |
| Frew, R | 1 |
| Guo, X | 1 |
| Gong, Q | 1 |
| Borowiec, J | 1 |
| Han, S | 1 |
| Zhang, M | 1 |
| Willis, M | 1 |
| Kreouzis, T | 1 |
| Yu, K | 1 |
| Chirvony, VS | 1 |
| Sekerbayev, KS | 1 |
| Pérez-Del-Rey, D | 1 |
| Martínez-Pastor, JP | 1 |
| Palazon, F | 1 |
| Boix, PP | 1 |
| Taurbayev, TI | 1 |
| Sessolo, M | 1 |
| Bolink, HJ | 1 |
| Lu, M | 1 |
| Lan, Y | 1 |
| Xiao, J | 1 |
| Song, M | 1 |
| Chen, C | 1 |
| Huang, Q | 1 |
| Cao, Y | 1 |
| Ho, CT | 1 |
| Qi, B | 1 |
| Wang, Q | 1 |
| Zhang, W | 1 |
| Fang, L | 1 |
| Xie, CL | 1 |
| Chen, R | 1 |
| Yang, S | 1 |
| Xia, JM | 1 |
| Zhang, GY | 1 |
| Chen, CH | 1 |
| Yang, XW | 1 |
| Domenech-Ximenos, B | 1 |
| Garza, MS | 1 |
| Prat-González, S | 1 |
| Sepúlveda-Martínez, Á | 1 |
| Crispi, F | 1 |
| Perea, RJ | 1 |
| Garcia-Alvarez, A | 1 |
| Sitges, M | 1 |
| Kalumpha, M | 1 |
| Guyo, U | 1 |
| Zinyama, NP | 1 |
| Vakira, FM | 1 |
| Nyamunda, BC | 1 |
| Varga, M | 1 |
| Drácz, L | 1 |
| Kolbenheyer, E | 1 |
| Varga, F | 1 |
| Patai, ÁV | 1 |
| Solymosi, N | 1 |
| Patai, Á | 1 |
| Kiss, J | 1 |
| Gaál, V | 1 |
| Nyul, Z | 1 |
| Mosdósi, B | 1 |
| Valdez, M | 1 |
| Moosavi, L | 1 |
| Heidari, A | 1 |
| Novakovic-Agopian, T | 1 |
| Kornblith, E | 1 |
| Abrams, G | 1 |
| McQuaid, JR | 1 |
| Posecion, L | 1 |
| Burciaga, J | 1 |
| D'Esposito, M | 1 |
| Chen, AJW | 1 |
| Samy El Gendy, NM | 1 |
| Wesolowska, P | 1 |
| Georg, D | 1 |
| Lechner, W | 1 |
| Kazantsev, P | 1 |
| Bokulic, T | 1 |
| Tedgren, AC | 1 |
| Adolfsson, E | 1 |
| Campos, AM | 1 |
| Alves, VGL | 1 |
| Suming, L | 1 |
| Hao, W | 1 |
| Ekendahl, D | 1 |
| Koniarova, I | 1 |
| Bulski, W | 1 |
| Chelminski, K | 1 |
| Samper, JLA | 1 |
| Vinatha, SP | 1 |
| Rakshit, S | 1 |
| Siri, S | 1 |
| Tomsejm, M | 1 |
| Tenhunen, M | 1 |
| Povall, J | 1 |
| Kry, SF | 1 |
| Followill, DS | 1 |
| Thwaites, DI | 1 |
| Izewska, J | 1 |
| Kang, JH | 1 |
| Yoon, Y | 1 |
| Song, J | 1 |
| Van de Winckel, A | 1 |
| Gauthier, L | 1 |
| Chao, CT | 1 |
| Lee, YH | 1 |
| Li, CM | 1 |
| Han, DS | 1 |
| Huang, JW | 1 |
| Huang, KC | 1 |
| Ni, L | 1 |
| Güttinger, R | 1 |
| Triana, CA | 1 |
| Spingler, B | 1 |
| Baldridge, KK | 1 |
| Patzke, GR | 1 |
| Shen, X | 1 |
| Wang, B | 1 |
| Xie, S | 1 |
| Deng, W | 1 |
| Wu, D | 1 |
| Zhang, Q | 1 |
| Voskamp, BJ | 1 |
| Peelen, MJCS | 1 |
| Ravelli, ACJ | 1 |
| van der Lee, R | 1 |
| Mol, BWJ | 1 |
| Pajkrt, E | 1 |
| Ganzevoort, W | 1 |
| Kazemier, BM | 1 |
| Tibrewala, R | 1 |
| Bahroos, E | 1 |
| Mehrabian, H | 1 |
| Foreman, SC | 1 |
| Link, TM | 1 |
| Pedoia, V | 1 |
| Majumdar, S | 1 |
| Jablonski, CL | 1 |
| Leonard, C | 1 |
| Salo, P | 1 |
| Krawetz, RJ | 1 |
| Yoon, N | 1 |
| Hong, SN | 1 |
| Cho, JG | 1 |
| Jeong, HK | 1 |
| Lee, KH | 1 |
| Park, HW | 1 |
| Barman, S | 1 |
| Konai, MM | 1 |
| Samaddar, S | 1 |
| Haldar, J | 1 |
| Mohamed, HSH | 1 |
| Li, CF | 1 |
| Hu, ZY | 1 |
| Deng, Z | 1 |
| Chen, LH | 1 |
| Su, BL | 1 |
| Chu, K | 1 |
| Liu, YP | 1 |
| Li, YB | 1 |
| Zhang, H | 1 |
| Xu, C | 1 |
| Zou, Z | 1 |
| Wu, Z | 1 |
| Xia, Y | 1 |
| Zhao, P | 1 |
| Wang, HT | 1 |
| de Biase, S | 1 |
| Pellitteri, G | 1 |
| Gigli, GL | 1 |
| Valente, M | 1 |
| Wesson, DE | 2 |
| Buysse, JM | 1 |
| Bushinsky, DA | 1 |
| Agarwal, A | 1 |
| Cheung, AK | 1 |
| Whaley-Connell, A | 1 |
| Sowers, JR | 2 |
| Lyubarova, R | 1 |
| Gosmanova, EO | 1 |
| Wakino, S | 1 |
| Minakuchi, H | 1 |
| Miya, K | 1 |
| Takamatsu, N | 1 |
| Tada, H | 1 |
| Tani, E | 1 |
| Inamoto, H | 1 |
| Minakuchi, J | 1 |
| Kawashima, S | 1 |
| Itoh, H | 3 |
| Piecha, G | 1 |
| Kujawa-Szewieczek, A | 1 |
| Kuczera, P | 1 |
| Skiba, K | 1 |
| Sikora-Grabka, E | 1 |
| Więcek, A | 3 |
| Charytan, DM | 1 |
| Himmelfarb, J | 1 |
| Ikizler, TA | 1 |
| Raj, DS | 1 |
| Hsu, JY | 1 |
| Landis, JR | 1 |
| Anderson, AH | 1 |
| Hung, AM | 1 |
| Mehrotra, R | 1 |
| Sharma, S | 1 |
| Weiner, DE | 1 |
| Williams, M | 1 |
| DiCarli, M | 1 |
| Skali, H | 1 |
| Kimmel, PL | 1 |
| Kliger, AS | 1 |
| Dember, LM | 1 |
| Artunc, F | 1 |
| Wörn, M | 1 |
| Schork, A | 1 |
| Bohnert, BN | 1 |
| Hessels, NR | 1 |
| van den Bosch, JJON | 1 |
| van Londen, M | 1 |
| Bakker, SJL | 1 |
| Riphagen, IJ | 1 |
| Navis, GJ | 1 |
| Rugale, C | 1 |
| Du Cailar, G | 1 |
| Fesler, P | 1 |
| Ribstein, J | 1 |
| Mourad, G | 1 |
| Mimran, A | 1 |
| Issa, N | 1 |
| Ortiz, F | 1 |
| Reule, SA | 1 |
| Kukla, A | 1 |
| Kasiske, BL | 1 |
| Mauer, M | 1 |
| Jackson, S | 1 |
| Matas, AJ | 1 |
| Ibrahim, HN | 1 |
| Najafian, B | 1 |
| Fernández-Juárez, G | 1 |
| Luño, J | 1 |
| Barrio, V | 1 |
| de Vinuesa, SG | 1 |
| Praga, M | 1 |
| Goicoechea, M | 1 |
| Lahera, V | 1 |
| Casas, L | 1 |
| Oliva, J | 1 |
| Arregger, AL | 2 |
| Cardoso, EM | 2 |
| Zucchini, A | 1 |
| Aguirre, EC | 1 |
| Elbert, A | 1 |
| Contreras, LN | 2 |
| Deo, R | 1 |
| Yang, W | 1 |
| Khan, AM | 1 |
| Bansal, N | 1 |
| Leonard, MB | 1 |
| Keane, MG | 1 |
| Soliman, EZ | 1 |
| Steigerwalt, S | 2 |
| Townsend, RR | 1 |
| Shlipak, MG | 1 |
| Feldman, HI | 1 |
| Torres, VE | 1 |
| Abebe, KZ | 1 |
| Chapman, AB | 1 |
| Schrier, RW | 6 |
| Braun, WE | 1 |
| Steinman, TI | 2 |
| Winklhofer, FT | 1 |
| Brosnahan, G | 1 |
| Czarnecki, PG | 1 |
| Hogan, MC | 1 |
| Miskulin, DC | 1 |
| Rahbari-Oskoui, FF | 1 |
| Grantham, JJ | 1 |
| Harris, PC | 1 |
| Flessner, MF | 1 |
| Moore, CG | 1 |
| Perrone, RD | 1 |
| Schwenk, MH | 1 |
| Hirsch, JS | 1 |
| Bomback, AS | 6 |
| Abd ElHafeez, S | 1 |
| Tripepi, G | 1 |
| Mallamaci, F | 1 |
| Zoccali, C | 1 |
| Georgianos, PI | 1 |
| Sarafidis, PA | 1 |
| Liakopoulos, V | 1 |
| Balaskas, EV | 1 |
| Zebekakis, PE | 1 |
| Hung, SC | 1 |
| Tarng, DC | 1 |
| Wolf, G | 1 |
| Mishina, M | 1 |
| Watanabe, T | 1 |
| Graf, K | 1 |
| Hucko, T | 1 |
| Stawowy, P | 1 |
| Fujita, T | 3 |
| Karabayeva, AZh | 1 |
| Esaian, AM | 1 |
| Kayukov, IG | 1 |
| Parastaeva, MM | 1 |
| Beresneva, ON | 1 |
| Kotenko, LV | 1 |
| Sevastyanova, IE | 1 |
| Klemmer, PJ | 4 |
| Ku, E | 2 |
| Campese, VM | 2 |
| Takemitsu, T | 1 |
| Ichihara, A | 1 |
| Kaneshiro, Y | 1 |
| Sakoda, M | 1 |
| Kurauchi-Mito, A | 1 |
| Narita, T | 1 |
| Kinouchi, K | 1 |
| Yamashita, N | 1 |
| Farese, S | 1 |
| Kruse, A | 1 |
| Pasch, A | 1 |
| Dick, B | 1 |
| Frey, BM | 1 |
| Uehlinger, DE | 1 |
| Frey, FJ | 1 |
| Jain, G | 1 |
| Campbell, RC | 1 |
| Warnock, DG | 2 |
| Steele, JL | 1 |
| Henik, RA | 2 |
| Stepien, RL | 1 |
| Kshirsagar, AV | 1 |
| Ferris, ME | 1 |
| Yeyati, NL | 1 |
| Altuna, ME | 1 |
| Damasco, MC | 1 |
| Mac Laughlin, MA | 1 |
| Kojima, Y | 1 |
| Miyake, O | 1 |
| Morimoto, A | 1 |
| Kawamura, C | 1 |
| Katayama, S | 1 |
| Nakayama, M | 2 |
| Nakano, H | 1 |
| Kadomatsu, K | 1 |
| Masoumi, A | 1 |
| Elhassan, E | 1 |
| Hammer, F | 1 |
| Edwards, NC | 1 |
| Hughes, BA | 1 |
| Steeds, RP | 1 |
| Ferro, CJ | 1 |
| Townend, JN | 1 |
| Stewart, PM | 1 |
| Nakano, N | 1 |
| Ishimitsu, T | 1 |
| Takahashi, T | 1 |
| Inada, H | 1 |
| Okamura, A | 1 |
| Ohba, S | 1 |
| Matsuoka, H | 1 |
| Lu, Y | 1 |
| Lastra, G | 1 |
| Dhuper, S | 1 |
| Johnson, MS | 1 |
| Kujal, P | 1 |
| Chábová, VČ | 1 |
| Vernerová, Z | 1 |
| Walkowska, A | 1 |
| Kompanowska-Jezierska, E | 1 |
| Sadowski, J | 1 |
| Vaňourková, Z | 1 |
| Husková, Z | 1 |
| Opočenský, M | 1 |
| Skaroupková, P | 1 |
| Schejbalová, S | 1 |
| Kramer, HJ | 2 |
| Rakušan, D | 1 |
| Malý, J | 1 |
| Netuka, I | 1 |
| Vaněčková, I | 1 |
| Kopkan, L | 1 |
| Cervenka, L | 1 |
| Fox, CS | 1 |
| Gona, P | 1 |
| Larson, MG | 1 |
| Selhub, J | 1 |
| Tofler, G | 1 |
| Hwang, SJ | 1 |
| Meigs, JB | 1 |
| Levy, D | 1 |
| Wang, TJ | 1 |
| Jacques, PF | 1 |
| Benjamin, EJ | 1 |
| Vasan, RS | 1 |
| Simoni, J | 1 |
| Broglio, K | 1 |
| Sheather, S | 1 |
| Bertocchio, JP | 1 |
| Jaisser, F | 1 |
| Yan, TK | 1 |
| Jia, JY | 1 |
| Lin, S | 1 |
| Volk, MJ | 1 |
| Waanders, F | 1 |
| de Vries, LV | 1 |
| van Goor, H | 1 |
| Hillebrands, JL | 1 |
| Laverman, GD | 1 |
| Bakker, SJ | 1 |
| Navis, G | 1 |
| Shibata, S | 2 |
| Sim, JJ | 1 |
| Shi, J | 1 |
| Calara, F | 1 |
| Rasgon, S | 1 |
| Jacobsen, S | 1 |
| Kalantar-Zadeh, K | 1 |
| Suzuki, R | 1 |
| Honda, H | 1 |
| Niikura, K | 1 |
| Akizawa, T | 1 |
| Ring, T | 1 |
| Shavit, L | 1 |
| Lifschitz, MD | 1 |
| Epstein, M | 3 |
| Pitt, B | 1 |
| Filippatos, G | 1 |
| Gheorghiade, M | 1 |
| Kober, L | 1 |
| Krum, H | 1 |
| Ponikowski, P | 1 |
| Nowack, C | 1 |
| Kolkhof, P | 1 |
| Kim, SY | 1 |
| Zannad, F | 1 |
| Terata, S | 1 |
| Kikuya, M | 1 |
| Satoh, M | 1 |
| Ohkubo, T | 1 |
| Hashimoto, T | 1 |
| Hara, A | 2 |
| Hirose, T | 1 |
| Obara, T | 1 |
| Metoki, H | 1 |
| Inoue, R | 1 |
| Asayama, K | 1 |
| Kanno, A | 1 |
| Totsune, K | 1 |
| Hoshi, H | 1 |
| Satoh, H | 1 |
| Sato, H | 1 |
| Imai, Y | 2 |
| Bhandari, S | 1 |
| Gaedeke, J | 1 |
| Noble, NA | 1 |
| Border, WA | 1 |
| Furuya, R | 1 |
| Kumagai, H | 2 |
| Sakao, T | 1 |
| Maruyama, Y | 1 |
| Hishida, A | 2 |
| Rayner, BL | 1 |
| Owen, EP | 1 |
| King, JA | 1 |
| Soule, SG | 1 |
| Vreede, H | 1 |
| Opie, LH | 1 |
| Marais, D | 1 |
| Davidson, JS | 1 |
| Koshiyama, H | 1 |
| Fujisawa, T | 1 |
| Kuwamura, N | 1 |
| Nakamura, Y | 1 |
| Kanamori, H | 1 |
| Oida, E | 1 |
| Suzuki, T | 1 |
| Sasano, H | 1 |
| Hussain, S | 1 |
| Dreyfus, DE | 1 |
| Marcus, RJ | 1 |
| Biederman, RW | 1 |
| McGill, RL | 1 |
| Saudan, P | 1 |
| Mach, F | 1 |
| Perneger, T | 1 |
| Schnetzler, B | 1 |
| Stoermann, C | 1 |
| Fumeaux, Z | 1 |
| Rossier, M | 1 |
| Martin, PY | 1 |
| Wańkowicz, Z | 1 |
| Diskin, CJ | 2 |
| Stokes, TJ | 1 |
| Dansby, LM | 1 |
| Carter, TB | 1 |
| Radcliff, L | 1 |
| Martin, R | 1 |
| Arrizurieta de Muchnik, E | 1 |
| Endemann, DH | 1 |
| Wolf, K | 1 |
| Boeger, CA | 1 |
| Riegger, GA | 1 |
| Krämer, BK | 3 |
| Michea, L | 1 |
| Vukusich, A | 1 |
| González, M | 1 |
| Zehnder, C | 1 |
| Marusic, ET | 1 |
| Gross, E | 1 |
| Rothstein, M | 1 |
| Dombek, S | 1 |
| Juknis, HI | 1 |
| Muto, S | 1 |
| Sebata, K | 1 |
| Watanabe, H | 1 |
| Shoji, F | 1 |
| Yamamoto, Y | 1 |
| Ohashi, M | 1 |
| Yamada, T | 2 |
| Matsumoto, H | 1 |
| Mukouyama, T | 1 |
| Yonekura, T | 1 |
| Namiki, S | 1 |
| Kusano, E | 1 |
| Shimizu, MH | 1 |
| Coimbra, TM | 1 |
| de Araujo, M | 1 |
| Menezes, LF | 1 |
| Seguro, AC | 1 |
| Covic, A | 1 |
| Gusbeth-Tatomir, P | 1 |
| Goldsmith, DJ | 1 |
| Donderski, R | 1 |
| Grajewska, M | 1 |
| Manitius, J | 1 |
| Topcu, SO | 1 |
| Pedersen, M | 1 |
| Nørregaard, R | 1 |
| Wang, G | 1 |
| Knepper, M | 1 |
| Djurhuus, JC | 1 |
| Nielsen, S | 1 |
| Jørgensen, TM | 1 |
| Frøkiaer, J | 1 |
| Hartman, D | 1 |
| Doulton, TW | 1 |
| Chesters, CA | 1 |
| Sagnella, GA | 1 |
| MacGregor, GA | 1 |
| Nagase, M | 2 |
| Yoshida, S | 1 |
| Nagase, T | 1 |
| Gotoda, T | 1 |
| Ando, K | 1 |
| Kazory, A | 1 |
| Weiner, ID | 1 |
| Wenzel, U | 1 |
| Zafar, A | 1 |
| Mesiha, N | 1 |
| Gardin, J | 1 |
| Provenzano, R | 1 |
| Handler, J | 1 |
| Haddad, N | 1 |
| Rajan, J | 1 |
| Nagaraja, HN | 1 |
| Agarwal, AK | 1 |
| Hebert, LA | 1 |
| Ponda, MP | 1 |
| Hostetter, TH | 3 |
| Hong, ZR | 1 |
| Gil, HW | 1 |
| Yang, JO | 1 |
| Lee, EY | 1 |
| Ahn, JO | 1 |
| Hong, SY | 1 |
| Tumilasci, O | 1 |
| Giudicelli, JF | 1 |
| Chaignon, M | 2 |
| Richer, C | 1 |
| Giroux, B | 1 |
| Guedon, J | 2 |
| Kornerup, HJ | 1 |
| Schmitz, O | 1 |
| Danielsen, H | 3 |
| Pedersen, EB | 3 |
| Giese, J | 1 |
| Davies, RO | 1 |
| Gomez, HJ | 1 |
| Irvin, JD | 1 |
| Walker, JF | 1 |
| Bia, MJ | 1 |
| DeFronzo, RA | 1 |
| Kotchen, TA | 1 |
| Guthrie, GP | 1 |
| Maillet, CM | 1 |
| Garber, AJ | 1 |
| Drüeke, T | 1 |
| Waeber, B | 1 |
| Gavras, I | 1 |
| Brunner, HR | 1 |
| Cook, CA | 1 |
| Charocopos, F | 1 |
| Gavras, HP | 1 |
| Winer, RL | 1 |
| Rajudin, MM | 1 |
| Skowsky, WR | 1 |
| Parker, LN | 1 |
| Zager, PG | 3 |
| Luetscher, JA | 2 |
| Cooke, CR | 2 |
| Gann, DS | 1 |
| Whelton, PK | 2 |
| Hsu, TH | 1 |
| Bledsoe, T | 2 |
| Moore, MA | 2 |
| Walker, WG | 2 |
| Frey, HJ | 2 |
| Gerdes, BG | 1 |
| Arrizabalaga, P | 1 |
| Montoliu, J | 1 |
| Martinez Vea, A | 1 |
| Andreu, L | 1 |
| López Pedret, J | 2 |
| Revert, L | 2 |
| Hory, B | 1 |
| Henriet, MT | 1 |
| Abe, K | 1 |
| Haruyama, T | 1 |
| Sato, M | 1 |
| Yasujima, M | 1 |
| Seino, M | 1 |
| Chiba, S | 1 |
| Hiwatari, M | 1 |
| Kasai, Y | 1 |
| Tajima, J | 1 |
| Itoh, S | 1 |
| Yoshinaga, K | 2 |
| Acchiardo, SR | 1 |
| Skoutakis, VA | 1 |
| Lifshchits, NL | 1 |
| Ermolenko, VM | 2 |
| Mysliwiec, M | 1 |
| Myśliwiec, B | 1 |
| Maher, T | 1 |
| Schambelan, M | 2 |
| Kurtz, I | 1 |
| Hulter, HN | 1 |
| Jones, JW | 1 |
| Sebastian, A | 3 |
| Rauh, W | 2 |
| Hund, E | 1 |
| Sohl, G | 1 |
| Rascher, W | 2 |
| Mehls, O | 1 |
| Schärer, K | 2 |
| Bernardi, M | 2 |
| Wilkinson, SP | 2 |
| Wernze, H | 1 |
| Spech, HJ | 1 |
| Müller, G | 1 |
| Poston, L | 1 |
| Williams, R | 1 |
| Hené, RJ | 4 |
| Koomans, HA | 4 |
| Boer, P | 6 |
| Roos, JC | 2 |
| Dorhout Mees, EJ | 3 |
| Mehta, BR | 1 |
| Cavallo, T | 1 |
| Remmers, AR | 1 |
| DuBose, TD | 2 |
| Yang, CS | 1 |
| Lee, SH | 1 |
| Hung, SS | 1 |
| Weidmann, P | 11 |
| Chan, JC | 1 |
| Wambach, G | 1 |
| Breuer, G | 1 |
| Kaufmann, W | 1 |
| Perez, GO | 4 |
| Pelleya, R | 1 |
| Oster, JR | 4 |
| Kem, DC | 1 |
| Vaamonde, CA | 2 |
| Ruilope, L | 2 |
| Garcia Robles, P | 1 |
| Bernis, C | 1 |
| Barrientos, A | 1 |
| Alcazar, J | 1 |
| Tresguerres, JA | 1 |
| Sancho, J | 2 |
| Rodicio, JL | 3 |
| Honda, N | 1 |
| Sudo, M | 1 |
| Carretero, OA | 1 |
| Scicli, AG | 1 |
| Horký, K | 3 |
| Gregorová, I | 2 |
| Chen, WY | 1 |
| Hsieh, BS | 1 |
| Lien, WP | 1 |
| Chen, FW | 1 |
| Yen, TS | 1 |
| Tan, SY | 1 |
| Burton, M | 1 |
| Farinelli, A | 1 |
| Squerzanti, R | 1 |
| De Paoli Vitali, E | 1 |
| Bagni, B | 1 |
| Cavallini, AR | 1 |
| Gilli, P | 1 |
| Bedani, PL | 1 |
| Louis, F | 1 |
| Zwahlen, A | 1 |
| Favre, H | 2 |
| Vallotton, M | 1 |
| Küppers, H | 5 |
| Banzhaf, R | 1 |
| Schnurr, E | 5 |
| Glasson, P | 1 |
| Leski, M | 1 |
| Saruta, T | 2 |
| Nagahama, S | 1 |
| Eguchi, T | 1 |
| Oka, M | 1 |
| Kanbegawa, A | 1 |
| Rado, JP | 3 |
| Mizuno, K | 1 |
| Gotoh, M | 1 |
| Matsui, J | 1 |
| Fukuchi, S | 7 |
| Mees, EJ | 1 |
| Nonoguchi, H | 1 |
| Miyagawa, H | 1 |
| Shinohara, S | 1 |
| Ida, T | 1 |
| Tomida, K | 1 |
| Elenkova, A | 1 |
| Stefanov, G | 1 |
| Trevisani, F | 1 |
| Santini, C | 1 |
| Pini, P | 1 |
| Turci, P | 1 |
| Kokot, F | 5 |
| Bodziony, D | 1 |
| Sudo, S | 1 |
| Takahashi, M | 2 |
| Yasuda, G | 1 |
| Nagasawa, T | 1 |
| Umemura, S | 1 |
| Shionoiri, H | 1 |
| Ishii, M | 2 |
| Gómez-Martino, JR | 1 |
| Miralles, JM | 1 |
| De Leon, B | 1 |
| Hernandez, MT | 1 |
| Tabernero, JM | 1 |
| Nami, R | 1 |
| Martinelli, M | 1 |
| Buracchi, P | 1 |
| Lucani, B | 1 |
| Panza, F | 1 |
| Pavese, G | 1 |
| Carletti, F | 1 |
| Saia, F | 1 |
| Gennari, C | 1 |
| Heintz, B | 2 |
| Königs, F | 1 |
| Dakshinamurty, KV | 1 |
| Kierdorf, H | 1 |
| Gladziwa, U | 2 |
| Kirsten, R | 2 |
| Nelson, K | 2 |
| Wieland, D | 2 |
| Riehl, J | 2 |
| Mann, H | 2 |
| Allon, M | 1 |
| Reiners, K | 1 |
| Sieberth, HG | 1 |
| Corry, DB | 1 |
| Tuck, ML | 2 |
| Letizia, C | 1 |
| Mazzaferro, S | 1 |
| Morabito, S | 1 |
| De Ciocchis, A | 1 |
| Cerci, S | 1 |
| D'Ambrosio, C | 1 |
| Cinotti, GA | 1 |
| Scavo, D | 2 |
| Yanagida, N | 1 |
| Okano, M | 1 |
| Ishizaki, A | 1 |
| Meguro, J | 1 |
| Kukita, K | 1 |
| Tamaki, T | 1 |
| Yonekawa, M | 1 |
| Kawamura, A | 1 |
| Yokoyama, T | 1 |
| Igaki, T | 1 |
| Suga, S | 1 |
| Hama, N | 1 |
| Ogawa, Y | 1 |
| Komatsu, Y | 1 |
| Mukoyama, M | 1 |
| Sugawara, A | 1 |
| Yoshimasa, T | 1 |
| Tanaka, I | 1 |
| Nakao, K | 1 |
| Cianciaruso, B | 2 |
| Bellizzi, V | 2 |
| Minutolo, R | 2 |
| Colucci, G | 2 |
| Bisesti, V | 1 |
| Russo, D | 1 |
| Conte, G | 2 |
| De Nicola, L | 2 |
| Kim, HJ | 1 |
| Clark, BA | 1 |
| Shannon, C | 1 |
| Brown, RS | 1 |
| Gervino, EV | 1 |
| Ebel, H | 1 |
| Laage, C | 1 |
| Keuchel, M | 1 |
| Dittmar, A | 1 |
| Saure, B | 1 |
| Ehlenz, K | 1 |
| Lange, H | 1 |
| Balletta, M | 1 |
| Fuiano, G | 1 |
| Jensen, J | 1 |
| Brownfield, M | 1 |
| Armstrong, J | 1 |
| Morineau, G | 1 |
| Pascoe, L | 1 |
| Marc, JM | 1 |
| Caillette, A | 1 |
| Krozowski, Z | 1 |
| Corvol, P | 2 |
| Fiet, J | 1 |
| Radó, J | 1 |
| Tóth, A | 1 |
| Haris, A | 1 |
| Hatch, M | 1 |
| Freel, RW | 1 |
| Vaziri, ND | 1 |
| Samuel-Variath, R | 1 |
| Chan, R | 1 |
| Michelis, MF | 2 |
| Ito, H | 1 |
| Sasaoka, A | 1 |
| Takao, T | 1 |
| Nishiya, K | 1 |
| Nanamiya, W | 1 |
| Chikazawa, H | 1 |
| Matsumoto, T | 1 |
| Kitagawa, S | 1 |
| Hishimoto, K | 1 |
| Miller, JA | 1 |
| Anacta, LA | 1 |
| Cattran, DC | 1 |
| Keilani, T | 1 |
| Danesh, FR | 1 |
| Schlueter, WA | 1 |
| Molteni, A | 1 |
| Batlle, D | 1 |
| Uusimaa, P | 1 |
| Huttunen, K | 1 |
| Ruskoaho, H | 1 |
| Linnaluoto, M | 1 |
| Ikäheimo, M | 1 |
| Barenbrock, M | 1 |
| Spieker, C | 1 |
| Hausberg, M | 1 |
| Rahn, KH | 1 |
| Zidek, W | 1 |
| Kisters, K | 1 |
| Lifshits, NL | 2 |
| Kutyrina, IM | 2 |
| Sato, A | 1 |
| Funder, JW | 1 |
| van Hoogstraten, HJ | 1 |
| van der Sluijs, JP | 1 |
| van der Meulen, J | 1 |
| Sica, DA | 2 |
| Halstenson, CE | 1 |
| Gehr, TW | 2 |
| Keane, WF | 1 |
| Okura, Y | 1 |
| Oshima, T | 1 |
| Yasunobu, Y | 1 |
| Amano, K | 1 |
| Mori, M | 1 |
| Shinozaki, K | 1 |
| Kajiyama, G | 1 |
| Krag, S | 1 |
| Osterby, R | 1 |
| Chai, Q | 1 |
| Nielsen, CB | 1 |
| Hermans, C | 1 |
| Wogensen, L | 1 |
| Grekas, D | 1 |
| Kalevrosoglou, I | 1 |
| Karamouzis, M | 1 |
| Geropoulou, E | 1 |
| Kabouris, H | 1 |
| Tourkantonis, A | 1 |
| Palamarchuk, MI | 1 |
| Kozlovskaia, LV | 1 |
| Balkarov, IM | 1 |
| Agarwal, R | 1 |
| Vlassopoulos, D | 1 |
| Sonikian, M | 1 |
| Dardioti, V | 1 |
| Pani, I | 1 |
| Hadjilouka-Mantaka, A | 1 |
| Hadjiconstantinou, V | 1 |
| Nowicki, M | 1 |
| Miszczak-Kuban, J | 1 |
| Gennari, FJ | 1 |
| Segal, AS | 1 |
| Szylman, P | 1 |
| Better, OS | 1 |
| Chaimowitz, C | 1 |
| Rosler, A | 1 |
| Morris, RC | 2 |
| Lindenfeld, S | 1 |
| Arruda, JA | 1 |
| Kurtzman, NA | 1 |
| Cugini, P | 1 |
| Manconi, R | 1 |
| Serdoz, R | 1 |
| Maxwell, MH | 7 |
| Rowe, P | 3 |
| Winer, R | 2 |
| Massry, SG | 2 |
| De Lima, J | 2 |
| Hirsch, D | 1 |
| Franklin, SS | 2 |
| Olgaard, K | 3 |
| Madsen, S | 3 |
| Arora, KK | 1 |
| Pfeifer, MA | 1 |
| Wolter, C | 1 |
| Melo, J | 1 |
| Samols, E | 1 |
| Hagen, C | 1 |
| Hummer, L | 1 |
| Lachmanová, J | 2 |
| Tomásek, R | 1 |
| Nakajima, K | 4 |
| Sekino, H | 1 |
| Ishizaki, M | 1 |
| Fisch, HP | 1 |
| Nigawara, K | 1 |
| Yagihashi, Y | 1 |
| Kogawa, T | 1 |
| Kawamata, A | 1 |
| Yamaya, K | 1 |
| Sugawara, S | 1 |
| Tulachan, Y | 1 |
| Funyu, T | 1 |
| Eba, H | 1 |
| Kido, K | 1 |
| Tanaka, T | 2 |
| Morita, S | 1 |
| Fukushi, M | 1 |
| Furusawa, M | 1 |
| Terayama, Y | 1 |
| Hirayama, N | 1 |
| Farfel, Z | 1 |
| Iaina, A | 1 |
| Eliahou, HE | 1 |
| Ladefoged, J | 1 |
| Regeur, L | 1 |
| Sparano, F | 2 |
| Giaquinto, G | 2 |
| Odoardi, A | 2 |
| Mercuri, MA | 2 |
| Tosti-Croce, C | 1 |
| Sulon, J | 1 |
| Sciarra, F | 2 |
| Galeazzi, RL | 1 |
| Gugger, M | 1 |
| Botey, A | 1 |
| Bestard, J | 1 |
| Mauri, M | 1 |
| Matsui, G | 1 |
| Pratt, JH | 1 |
| Grim, CE | 1 |
| Parkinson, CA | 1 |
| Tatsievskiĭ, VA | 1 |
| Khu, LCh | 1 |
| Yoshida, N | 1 |
| Shimizu, N | 1 |
| Kamiko, J | 1 |
| Nagazaka, H | 1 |
| Arakawa, M | 1 |
| Caputo, RA | 1 |
| Coe, FL | 1 |
| Brezis, M | 1 |
| Litvin, Y | 1 |
| Henrich, WL | 2 |
| Katz, FH | 3 |
| Molinoff, PB | 1 |
| Caron, C | 1 |
| Nawar, T | 1 |
| Montambault, P | 1 |
| Plante, GE | 1 |
| Kandalaft, N | 1 |
| Bank, N | 1 |
| Lief, PD | 1 |
| Piczon, O | 1 |
| Berl, T | 2 |
| de Torrente, A | 1 |
| Gavras, H | 1 |
| Oliver, JA | 1 |
| Cannon, PJ | 1 |
| Vetter, W | 5 |
| Záruba, K | 4 |
| Armbruster, H | 4 |
| Beckerhoff, R | 5 |
| Uhlschmid, G | 2 |
| Furrer, J | 2 |
| Siegenthaler, W | 5 |
| Grabensee, B | 4 |
| Nussberger, J | 2 |
| Fontana, A | 1 |
| Zusman, RM | 1 |
| Axelrod, L | 1 |
| Tolkoff-Rubin, N | 1 |
| van Ypersele de Strihou, C | 1 |
| Müller-Wiefel, DE | 1 |
| Heide, B | 1 |
| Concolino, G | 1 |
| Kuska, J | 1 |
| Yamamoto, T | 1 |
| Doi, K | 1 |
| Ogihara, T | 1 |
| Ichihara, K | 1 |
| Hata, T | 1 |
| Kumahara, Y | 1 |
| Brown, JJ | 5 |
| Brown, WC | 1 |
| Fraser, R | 3 |
| Lever, AF | 5 |
| Morton, JJ | 1 |
| Robertson, JI | 5 |
| Rosei, EA | 1 |
| Trust, PM | 1 |
| Deheneffe, J | 1 |
| Castermans, R | 1 |
| Suc, JM | 3 |
| Kleeman, CR | 2 |
| Levi, J | 1 |
| Better, O | 1 |
| Leenen, FH | 2 |
| Galla, SJ | 2 |
| Redmond, DP | 2 |
| Vagnucci, AH | 4 |
| McDonald, RH | 2 |
| Shapiro, AP | 2 |
| Higashi, F | 1 |
| del Greco, F | 1 |
| Wiesen, K | 1 |
| Jin, H | 1 |
| Yuan, ZY | 1 |
| Du, XH | 1 |
| Risler, T | 3 |
| Schweicker, M | 1 |
| Braun, U | 1 |
| Erley, E | 1 |
| Konstantinov, IuV | 2 |
| Shulutko, BI | 2 |
| Tsanava, KA | 1 |
| Konstantinova, IV | 1 |
| Spital, A | 1 |
| Solomon, R | 1 |
| Dubey, A | 1 |
| La Villa, G | 1 |
| Romanelli, RG | 1 |
| Casini Raggi, V | 1 |
| Tosti-Guerra, C | 1 |
| De Feo, ML | 1 |
| Marra, F | 1 |
| Laffi, G | 1 |
| Gentilini, P | 1 |
| Arik, N | 1 |
| Demirkan, F | 1 |
| Erbas, B | 1 |
| Arinsoy, T | 1 |
| Sungur, C | 1 |
| Yasavul, U | 1 |
| Turgan, C | 1 |
| Koray, Z | 1 |
| Caglar, S | 1 |
| Selçuk, Y | 1 |
| San, A | 1 |
| Bakan, E | 1 |
| Yiğitoğlu, R | 1 |
| Grasela, DM | 1 |
| Fakhry, I | 1 |
| Davis, J | 1 |
| Duchin, KL | 1 |
| Takagi, T | 1 |
| Nishikawa, M | 1 |
| Mori, Y | 1 |
| Matsubara, H | 1 |
| Inada, M | 1 |
| Girolami, JP | 1 |
| Bascands, JL | 1 |
| Vega Vidalle, C | 1 |
| Pecher, C | 1 |
| Moatti, JP | 1 |
| Adam, A | 1 |
| Yoshida, A | 1 |
| Morozumi, K | 1 |
| Suganuma, T | 1 |
| Aoki, J | 1 |
| Sugito, K | 1 |
| Nakamura, S | 1 |
| Ikeda, M | 1 |
| Oikawa, T | 1 |
| Fujinami, T | 1 |
| Kawahara, H | 1 |
| de Fijter, CW | 1 |
| Comans, EF | 1 |
| de Vries, PM | 1 |
| Oe, PL | 1 |
| Smit, AJ | 1 |
| Streurman, O | 1 |
| Donker, AJ | 1 |
| Dussaule, JC | 1 |
| Michel, C | 1 |
| Wolf, JP | 1 |
| Czekalski, S | 1 |
| Mignon, F | 1 |
| Ardaillou, R | 1 |
| Grzeszczak, W | 3 |
| Zukowska-Szczechowska, E | 2 |
| Ulshöfer, TM | 2 |
| Müller, GA | 1 |
| Ress, KM | 2 |
| Rosenberg, ME | 2 |
| Swanson, JE | 2 |
| Thomas, BL | 2 |
| Mann, JF | 1 |
| Reisch, C | 1 |
| Bergbreiter, R | 1 |
| Karcher, D | 1 |
| Hackenthal, E | 2 |
| Vecsei, P | 1 |
| Ritz, E | 2 |
| Ramirez, G | 1 |
| Ganguly, A | 1 |
| Bruegemeyer, C | 1 |
| Gomez-Sanchez, C | 1 |
| Schohn, D | 1 |
| Gnädinger, MP | 1 |
| Bürgisser, E | 1 |
| Ferrier, C | 2 |
| Jahn, H | 1 |
| Koshida, H | 1 |
| Miyamori, I | 2 |
| Miyazaki, R | 1 |
| Tofuku, Y | 1 |
| Takeda, R | 2 |
| Stemmer, CL | 1 |
| Novo, S | 2 |
| Adamo, L | 2 |
| Giamporcaro, A | 2 |
| Forte, G | 2 |
| Longo, B | 1 |
| Gallo, VB | 1 |
| Licata, G | 1 |
| Strano, A | 2 |
| Espiner, EA | 1 |
| Nicholls, MG | 1 |
| Yandle, TG | 1 |
| Crozier, IG | 1 |
| Cuneo, RC | 1 |
| McCormick, D | 1 |
| Ikram, H | 1 |
| Suda, S | 1 |
| Saxenhofer, H | 1 |
| Cottier, C | 1 |
| Shaw, SG | 1 |
| Srámková, J | 1 |
| Tesar, V | 1 |
| Widimský, J | 1 |
| Andersson, U | 1 |
| Sylvén, C | 1 |
| Lindvall, K | 1 |
| Theodorsson, E | 1 |
| Norée, LO | 1 |
| Tiberio López, G | 1 |
| Tanco, S | 1 |
| Orradre, B | 1 |
| Berrade, MF | 1 |
| Anderiz López, M | 1 |
| Zanella, MT | 1 |
| Mattei, E | 1 |
| Draibe, SA | 1 |
| Kater, CE | 1 |
| Ajzen, H | 1 |
| Galfano, G | 1 |
| Ferrara, D | 1 |
| Krimkevich, EI | 1 |
| Petrun', NM | 1 |
| Baran, EIa | 1 |
| Kutsaĭ, NN | 1 |
| Khomenko, NV | 1 |
| Billaud-Mesguich, E | 1 |
| Alexandre, JM | 1 |
| van Schaik, BA | 1 |
| Geyskes, GG | 1 |
| Gross, P | 1 |
| Ketteler, M | 1 |
| Hausmann, C | 1 |
| Reinhard, C | 1 |
| Schömig, A | 1 |
| Blumberg, A | 1 |
| Shaw, S | 1 |
| Gnädinger, M | 1 |
| Chmielewski, D | 1 |
| García-Robles, R | 1 |
| Tovar, J | 1 |
| de Villa, LF | 1 |
| Miranda, B | 2 |
| Prieto, C | 1 |
| Parada, J | 1 |
| Nikishova, TA | 1 |
| Tareyeva, IE | 1 |
| Durand, D | 1 |
| Ader, JL | 1 |
| Rey, JP | 1 |
| Tran-Van, T | 1 |
| Lloveras, JJ | 1 |
| Bernadet, P | 1 |
| Jespersen, B | 2 |
| Christensen, NJ | 1 |
| Sørensen, SS | 2 |
| Bantle, JP | 1 |
| Boudreau, RJ | 1 |
| Ferris, TF | 2 |
| Zabetakis, PM | 1 |
| Kumar, DN | 1 |
| Gleim, GW | 1 |
| Gardenswartz, MH | 1 |
| Agrawal, M | 1 |
| Robinson, AG | 1 |
| Swainson, CP | 1 |
| Griffiths, P | 1 |
| Watson, ML | 1 |
| Nadler, JL | 1 |
| Lee, FO | 1 |
| Hsueh, W | 1 |
| Horton, R | 2 |
| Dordević, V | 1 |
| Kostić, S | 1 |
| Stefanović, V | 2 |
| Spalding, CT | 1 |
| Brittenham, MC | 1 |
| Leor, R | 1 |
| Stalnikowicz, R | 1 |
| Hashimoto, H | 1 |
| Ohba, H | 1 |
| Abe, M | 1 |
| Yagi, S | 2 |
| Davidson, MB | 1 |
| Asp, N | 1 |
| Schultze, RG | 1 |
| Ivić, M | 1 |
| Strahinjić, S | 1 |
| Krishna, GG | 1 |
| Chusid, P | 1 |
| Hoeldtke, RD | 1 |
| Martin, RS | 1 |
| Panese, S | 1 |
| Virginillo, M | 1 |
| Gimenez, M | 1 |
| Litardo, M | 1 |
| Arrizurieta, E | 1 |
| Hayslett, JP | 2 |
| Sandle, GI | 1 |
| Gaiger, E | 1 |
| Tapster, S | 1 |
| Goodship, TH | 1 |
| Berg, KJ | 1 |
| Talseth, T | 1 |
| Iitake, K | 1 |
| Kimura, T | 1 |
| Matsui, K | 1 |
| Ota, K | 1 |
| Shoji, M | 1 |
| Inoue, M | 1 |
| Weinberg, MS | 1 |
| Azar, P | 1 |
| Trebbin, WM | 1 |
| Solomon, RJ | 1 |
| Schohn, DC | 1 |
| Schmitt, RL | 1 |
| Jahn, HA | 1 |
| Braden, GL | 1 |
| Geheb, MA | 1 |
| Shook, A | 1 |
| Singer, I | 1 |
| Cox, M | 1 |
| Bourgoignie, JJ | 1 |
| Gavellas, G | 1 |
| Van Putten, V | 1 |
| Nieto, J | 1 |
| Gutiérrez Millet, V | 1 |
| Gutiérrez Rodero, F | 1 |
| Alcázar, JM | 1 |
| Bello, I | 1 |
| Ruilope, LM | 1 |
| Perez, G | 1 |
| Barraclough, MA | 1 |
| Bacchus, B | 1 |
| Davies, DL | 1 |
| Gerstein, AR | 1 |
| Gold, EM | 1 |
| Gonick, HC | 1 |
| Feffer, ML | 1 |
| Maxwell, M | 1 |
| Ducrot, H | 1 |
| Meyer, P | 1 |
| Richet, G | 1 |
| Péquignot, H | 1 |
| Veyrat, R | 2 |
| Muller, AF | 2 |
| Mach, RS | 1 |
| Düsterdieck, G | 1 |
| Tree, M | 1 |
| Weir, RJ | 1 |
| Gross, F | 1 |
| Fichman, MP | 1 |
| Littenburg, G | 1 |
| Brooker, G | 1 |
| Mizukoshi, H | 1 |
| Miyazaki, T | 1 |
| Araki, Y | 1 |
| Takeuchi, T | 1 |
| Tsuchida, S | 1 |
| Sugawara, H | 1 |
| Reinhart, R | 1 |
| Coburn, JW | 1 |
| Hamet, P | 1 |
| Kuchel, O | 1 |
| Nowaczynski, W | 1 |
| rojo Ortega, JM | 1 |
| Sasaki, C | 1 |
| Genest, J | 1 |
| Stein, JH | 1 |
| Williams, GH | 1 |
| Bailey, GL | 1 |
| Hampers, CL | 1 |
| Lauler, DP | 1 |
| Merrill, JP | 1 |
| Underwood, RH | 1 |
| Blair-West, JR | 1 |
| Coghlan, JP | 1 |
| Denton, DA | 1 |
| Scoggins, BA | 1 |
| Wright, RD | 1 |
| Ikeda, T | 1 |
| Armbuster, H | 1 |
| Strebel, U | 1 |
| Oh, MS | 1 |
| Carroll, HJ | 1 |
| Clemmons, JE | 1 |
| Levison, SP | 1 |
| Whang, ES | 1 |
| Woods, TJ | 1 |
| McCaa, RE | 1 |
| Bower, JD | 1 |
| McCaa, CS | 1 |
| Bertagna, X | 1 |
| Bedrossian, J | 1 |
| Takenouchi, T | 1 |
| Nishisato, K | 1 |
| Reck, G | 1 |
| Bursztein, S | 1 |
| Cruz, IA | 1 |
| Dillard, MG | 1 |
| Hosten, AO | 1 |
| First, MR | 1 |
| Murphy, GP | 1 |
| Beevers, DG | 1 |
| Ferriss, JB | 1 |
| Nakagawa, S | 1 |
| Kitaoka, T | 1 |
| Koshikawa, S | 2 |
| Lupu, AN | 1 |
| Schroth, P | 1 |
| Regal, EM | 1 |
| Popovtzer, MM | 1 |
| Pinggera, WF | 1 |
| Robinette, J | 1 |
| Halgrimson, CG | 1 |
| Butkus, DE | 1 |
| Srour, M | 1 |
| Bourdy, H | 1 |
| Krück, F | 1 |
| Toussaint, C | 1 |
| Verniory, A | 1 |
| Naets, JP | 1 |
| Corvilain, J | 1 |
| Lambert, PP | 1 |
| Ueda, Y | 1 |
| Ogura, Y | 1 |
| Hanaoka, H | 1 |
| Ishida, M | 1 |
| Okamoto, T | 1 |
| Shiigai, T | 1 |
| Ideura, T | 1 |
| Kategawa, H | 1 |
| Holzgreve, H | 1 |
| Eigler, J | 1 |
| Wolfman, EF | 1 |
| Kowalczyk, RS | 1 |
| Trevino, G | 1 |
| Szende, L | 1 |
| Takó, J | 1 |
| Dévényi, I | 1 |
| Wilkinson, R | 1 |
| Dowdy, AJ | 1 |
| Gonzales, C | 1 |
| Nokes, GW | 1 |
| Vesin, P | 1 |
| Stokes, GS | 1 |
| Goldsmith, RF | 1 |
| Starr, LM | 1 |
| Gentle, JL | 1 |
| Mani, MK | 1 |
| Stewart, JH | 1 |
| Boyd, JE | 1 |
| Epstein, FH | 1 |
| Greder, G | 1 |
| Manning, EL | 1 |
| Jauffret, P | 1 |
| Garrigues, JC | 1 |
| Codaccioni, JL | 1 |
| Vague, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Controlled Interventional Trial to Investigate the Efficacy of Amiloride for the Treatment of Edema in Human Nephrotic Syndrome[NCT05079789] | Phase 3 | 20 participants (Actual) | Interventional | 2020-06-08 | Terminated (stopped due to Low recruiting rate and decision to evaluate as pilot study) | ||
| Angiotensin II Blockade for the Prevention of Cortical Interstitial Expansion and Graft Loss in Kidney Transplant Recipients[NCT00067990] | Phase 4 | 153 participants (Actual) | Interventional | 2002-12-31 | Completed | ||
| HALT Progression of Polycystic Kidney Disease Study B[NCT01885559] | Phase 3 | 486 participants (Actual) | Interventional | 2006-01-31 | Completed | ||
| Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients[NCT00384384] | Phase 2 | 24 participants | Interventional | 2006-08-31 | Completed | ||
| Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?[NCT00291720] | Phase 2 | 120 participants (Actual) | Interventional | 2005-04-30 | Completed | ||
| [NCT01832558] | 24 participants (Anticipated) | Interventional | 2012-11-30 | Recruiting | |||
| A Randomized, Double-blind, Multi-center Study to Assess Safety and Tolerability of Different Oral Doses of BAY94-8862 in Subjects With Stable Chronic Heart Failure With Left Ventricular Systolic Dysfunction and Mild (Part A) or Moderate (Part B) Chronic [NCT01345656] | Phase 2 | 457 participants (Actual) | Interventional | 2011-05-09 | Completed | ||
| Protective Mechanisms of Aldosterone Antagonists and Their Effects on Cardiovascular Damage in Chronic Renal Failure: Clinical and Experimental Studies[NCT00277693] | Phase 4 | 0 participants | Interventional | Recruiting | |||
| Haemodynamic Consequences of Changing Potassium Concentrations in Haemodialysis Fluids[NCT01224314] | 24 participants (Actual) | Interventional | 2007-09-30 | Completed | |||
| [NCT00005138] | 0 participants | Observational | 1976-06-30 | Completed | |||
| Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease[NCT00298129] | 278 participants (Actual) | Observational | 2004-02-29 | Completed | |||
| Pharmacokinetic Study of Propranolol, Losartan, and Eprosartan in Healthy Volunteers and Patients With Chronic Kidney Disease[NCT01087749] | Phase 1 | 24 participants (Actual) | Interventional | 2010-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Doubling of the interstitial or any defined ESRD (including IF/TA) (NCT00067990)
Timeframe: Baseline to 5 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Losartan | 6 |
| Placebo | 12 |
Number of subjects who had doubling of the interstitial or any end stage renal disease (ESRD) not attributed to interstitial fibrosis and tubular atrophy (IF/TA) (NCT00067990)
Timeframe: Baseline and 5 Years Post Transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Losartan | 7 |
| Placebo | 15 |
Annual percent change in 24 hour urine albumin, centrally processed. Data from multiple years were analyzed with the primary focus on the change over time for the measure (from the slope of the model). The measure presented is the average annual percent change across the 8 years. (NCT01885559)
Timeframe: up to 8 years (annually assessed)
| Intervention | annual percent change (Mean) |
|---|---|
| ACE-I + Placebo | 7.5 |
| ACE-I + ARB | 7.3 |
Annual percent change in urinary aldosterone, centrally processed measure. Data from multiple years were analyzed with the primary focus on the change over time for the measure (from the slope for time from the model). The measure presented is the average annual percent change across the 8 years. (NCT01885559)
Timeframe: up at 8 years (annually assessed)
| Intervention | annual percent change (Mean) |
|---|---|
| ACE-I + Placebo | -8.8 |
| ACE-I + ARB | -10.2 |
Report of back or flank pain since the last visit (yes or no) (NCT01885559)
Timeframe: 48 months
| Intervention | percentage of participants at 48 months (Number) |
|---|---|
| ACE-I + Placebo | 43 |
| ACE-I + ARB | 46 |
Cause-specific hospitalizations (cardiovascular) (NCT01885559)
Timeframe: up to 8 years
| Intervention | events (Number) |
|---|---|
| ACE-I + Placebo | 29 |
| ACE-I + ARB | 16 |
Hospitalization for any cause (NCT01885559)
Timeframe: up to 8 years
| Intervention | events (Number) |
|---|---|
| ACE-I + Placebo | 173 |
| ACE-I + ARB | 136 |
(NCT01885559)
Timeframe: Patients followed for 5-8 years with average of 6.5 years follow up
| Intervention | participants (Number) |
|---|---|
| ACE-I + Placebo | 116 |
| ACE-I + ARB | 115 |
Short Form-36 Quality of Life Mental Component Summary ranges from 0 (worst possible outcome) to 100 (best possible outcome). Data from multiple years were analyzed with the primary focus on the change over time for the measure (from the slope for time from the model). The measure presented is the average annual change across the 8 years. (NCT01885559)
Timeframe: up to 8 years (annually assessed)
| Intervention | units on a scale per year (Mean) |
|---|---|
| ACE-I + Placebo | -0.031 |
| ACE-I + ARB | -0.079 |
Short Form-36 Quality of Life Physical Component Summary ranges from 0 (worst possible outcome) to 100 (best possible outcome). Data from multiple years were analyzed with the primary focus on the change over time for the measure (from the slope for time from the model). The measure presented is the average annual change across the 8 years. (NCT01885559)
Timeframe: up to 8 years (annually assessed)
| Intervention | units on a scale per year (Mean) |
|---|---|
| ACE-I + Placebo | -0.64 |
| ACE-I + ARB | -0.68 |
65 reviews available for aldosterone and Chronic Kidney Failure
| Article | Year |
|---|---|
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Clinical Relevance; Diabetes Mellitus; Diabetic Nephr | 2023 |
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, P | 2019 |
Obesity and kidney disease: from population to basic science and the search for new therapeutic targets.
Topics: Aldosterone; Animals; Humans; Insulin Resistance; Kidney; Kidney Failure, Chronic; Obesity; Receptor | 2017 |
Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.
Topics: Aldosterone; Humans; Hypertension; Kidney Failure, Chronic; Mineralocorticoid Receptor Antagonists; | 2017 |
Proteasuria-The impact of active urinary proteases on sodium retention in nephrotic syndrome.
Topics: Aldosterone; Epithelial Sodium Channels; Homeostasis; Humans; Kidney Failure, Chronic; Nephrotic Syn | 2019 |
Aldosterone blockade in CKD: emphasis on pharmacology.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biological | 2015 |
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety.
Topics: Aldosterone; Blood Pressure; Disease Progression; Eplerenone; Heart Failure; Humans; Kidney Failure, | 2016 |
Reversed association between aldosterone and mortality in hemodialysis patients: Role of volume overload.
Topics: Aldosterone; Animals; Humans; Kidney Failure, Chronic; Renal Dialysis; Water-Electrolyte Imbalance | 2016 |
Novel aspects of the renin-angiotensin-aldosterone-system.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Humans; Kidney Diseases; Kidney Failure, Chro | 2008 |
Aldosterone and CKD in metabolic syndrome.
Topics: Albuminuria; Aldosterone; Biomarkers; Female; Humans; Kidney Failure, Chronic; Male; Metabolic Syndr | 2008 |
Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.
Topics: Aldosterone; Animals; Diabetes Complications; Humans; Hypertension; Insulin Resistance; Kidney; Kidn | 2009 |
Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anim | 2009 |
Mineralocorticoid receptor blockers and chronic kidney disease.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Chronic Disease; Drug Therapy, Combination; Hu | 2009 |
Midkine regulation of the renin-angiotensin system.
Topics: Acetylcholinesterase; Acute Kidney Injury; Aldosterone; Angiotensin II; Animals; Central Nervous Sys | 2010 |
Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Resistance; Dru | 2010 |
Aldosterone in the pathogenesis of chronic kidney disease and proteinuria.
Topics: Aldosterone; Disease Progression; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Miner | 2010 |
Salt, aldosterone, and insulin resistance: impact on the cardiovascular system.
Topics: Aldosterone; Cardiovascular Diseases; Cardiovascular System; Humans; Insulin Resistance; Kidney Fail | 2010 |
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease.
Topics: Aldosterone; Animals; Chronic Disease; Cyclosporine; Diabetic Nephropathies; Humans; Kidney Diseases | 2011 |
Mineralocorticoid receptor blockade in chronic kidney disease.
Topics: Aldosterone; Diabetes Mellitus; Humans; Hypertension; Inflammation; Kidney Failure, Chronic; Mineral | 2011 |
Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Homeostasis; Humans; | 2011 |
Mineralocorticoid receptors in the pathophysiology of chronic kidney diseases and the metabolic syndrome.
Topics: Aldosterone; Animals; Humans; Kidney Failure, Chronic; Metabolic Syndrome; Models, Biological; Rats; | 2012 |
Mineralocorticoid receptor blockade in chronic kidney disease.
Topics: Aldosterone; Animals; Diabetes Complications; Humans; Hyperaldosteronism; Kidney; Kidney Failure, Ch | 2012 |
Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms.
Topics: Aldosterone; Animals; Chelating Agents; Combined Modality Therapy; Disease Progression; Humans; Hype | 2012 |
Angiotensin II and progressive renal insufficiency.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Endothelins | 2002 |
A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Circadia | 2003 |
[Laboratory tests of endocrine system in chronic renal failure: benefits and risks].
Topics: Aldosterone; Calcitriol; Endocrine System Diseases; Erythropoietin; Hormones; Human Growth Hormone; | 2003 |
[The role of aldosterone in cardiovascular alterations in patients with chronic kidney disease].
Topics: Aldosterone; Coronary Artery Disease; Heart Failure; Humans; Kidney Failure, Chronic | 2006 |
Aldosterone antagonism in chronic kidney disease.
Topics: Aldosterone; Animals; Chronic Disease; Humans; Kidney Diseases; Kidney Failure, Chronic; Mineralocor | 2006 |
An overview of the clinical pharmacology of enalapril.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Di | 1984 |
Extrarenal potassium homeostasis.
Topics: Aldosterone; Animals; Dogs; Epinephrine; Glomerular Filtration Rate; Glucagon; Homeostasis; Humans; | 1981 |
Renin-angiotensin-aldosterone and hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Angiotensinogen; Angiotensins; Animals; Blood Press | 1980 |
[The functional role of aldosterone in patients with chronic kidney failure].
Topics: Aldosterone; Humans; Hypertension, Renal; Juxtaglomerular Apparatus; Kidney Failure, Chronic; Nephre | 1983 |
[Current theories on the hepatorenal syndrome].
Topics: Aldosterone; Humans; Kidney; Kidney Failure, Chronic; Liver; Liver Cirrhosis; Oliguria; Prostaglandi | 1983 |
Pathogenesis of hypertension associated with chronic renal failure.
Topics: Aldosterone; Autonomic Nervous System; Calcium; Catecholamines; Extracellular Space; Hemodynamics; H | 1984 |
Acid-base disorders and the kidney.
Topics: Acid-Base Equilibrium; Acid-Base Imbalance; Acidosis; Acidosis, Renal Tubular; Aldosterone; Alkalosi | 1983 |
The renal kallikrein-kinin system.
Topics: Acute Kidney Injury; Aldosterone; Angiotensins; Animals; Blood Pressure; Glomerular Filtration Rate; | 1980 |
Secondary aldosteronism.
Topics: Aldosterone; Blood Pressure; Edema; Female; Humans; Hyperaldosteronism; Hypertension, Renovascular; | 1995 |
Hyperkalemic hyperchloremic metabolic acidosis: pathophysiologic insights.
Topics: Acidosis; Acquired Immunodeficiency Syndrome; Adult; Aldosterone; Animals; Chlorides; Disease Models | 1997 |
Aldosterone-producing adrenocortical adenoma complicated by chronic renal failure. Case report and review of the literature.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Female; | 1998 |
Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Eplerenone; Humans; Hyper | 2001 |
Aldosterone as a mediator of progressive renal dysfunction: evolving perspectives.
Topics: Aldosterone; Animals; Clinical Trials as Topic; Disease Progression; Humans; Incidence; Kidney Failu | 2001 |
Hyperkalemia: An adaptive response in chronic renal insufficiency.
Topics: Adaptation, Physiological; Aldosterone; Animals; Homeostasis; Humans; Hyperkalemia; Kidney; Kidney F | 2002 |
Relationship of renal sodium and water transport to hydrogen ion secretion.
Topics: Acid-Base Equilibrium; Aldosterone; Animals; Bicarbonates; Blood Volume; Calcium; Dogs; Glomerular F | 1978 |
[Functional disorders of endocrine glands in chronic renal insufficiency].
Topics: Aldosterone; Angiotensin II; Calcium; Gastrins; Growth Hormone; Humans; Kidney Failure, Chronic; Par | 1979 |
Interrelations of renin, angiotensin II, and sodium in hypertension and renal failure.
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Animals; Blood Pressure; Glomerular Filtration Rat | 1976 |
The kidney in cirrhosis.
Topics: Acidosis, Renal Tubular; Aldosterone; Ascites; Diuretics; Hepatic Encephalopathy; Humans; Hypokalemi | 1976 |
[Malignant arterial hypertension].
Topics: Aldosterone; Angiotensin II; Antihypertensive Agents; Endarteritis; Female; Humans; Hypertension, Ma | 1975 |
Kidney and adrenocortical hormones.
Topics: Acidosis; Aldosterone; Animals; Calcium; Dogs; Glomerular Filtration Rate; Glucocorticoids; Humans; | 1975 |
The renin-angiotensin-aldosterone system in terminal renal failure.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Body Weight; Humans; Hypertension, Renal; Kidney Failur | 1975 |
Importance of opioid receptors in the pathogenesis of endocrine abnormalities in chronic renal failure.
Topics: Aldosterone; Endocrine System Diseases; Humans; Kidney Failure, Chronic; Pancreatic Hormones; Pituit | 1988 |
[Changes in renal function and the intracellular environment in cirrhotic patients].
Topics: Aldosterone; Body Fluids; Body Water; Bradykinin; Glomerular Filtration Rate; Humans; Intracellular | 1985 |
[Type IV renal tubular acidosis].
Topics: Acidosis, Renal Tubular; Aldosterone; Bicarbonates; Diabetes Complications; Humans; Hyperkalemia; Ki | 1985 |
Hypertension and chronic renal failure.
Topics: Aldosterone; Angiotensin II; Body Weight; Humans; Hypertension; Hypertension, Renal; Kidney Failure, | 1971 |
[Abnormalities of sodium and water metabolism with special reference to hypertensive diseases].
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hype | 1972 |
The physiology of renin.
Topics: Aldosterone; Angiotensin II; Edema; Extracellular Space; Female; Glomerular Filtration Rate; Humans; | 1973 |
[Renal insufficiency and renin-angiotensin-aldosterone].
Topics: Acute Kidney Injury; Adult; Aldosterone; Angiotensin II; Female; Humans; Hypertension, Renal; Kidney | 1974 |
Sodium handling by the kidney in health and disease. A review.
Topics: Absorption; Aldosterone; Animals; Biological Transport, Active; Blood Pressure; Capillaries; Diabete | 1973 |
Improvements of metabolic and diagnostic assessment of human renal allotransplants.
Topics: Adrenal Glands; Aldosterone; Anemia; Biopsy, Needle; Cholinesterases; Erythropoietin; Fibrin; Graft | 1972 |
The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aldosterone; Antihypertensive Agents; Carc | 1973 |
[Dynamics of water and sodium in renal insufficiency: in reference to therapeutic classification of disease stages].
Topics: Adolescent; Adult; Aldosterone; Diuretics; Furosemide; Humans; Kidney Concentrating Ability; Kidney | 1974 |
[Magnesium and the kidney].
Topics: Alcoholism; Aldosterone; Animals; Diuretics; Dogs; Humans; Kidney; Kidney Failure, Chronic; Magnesiu | 1968 |
[Clinical problems in body fluid balance].
Topics: Acid-Base Equilibrium; Aldosterone; Body Fluids; Diabetes Insipidus; Edema; Glomerular Filtration Ra | 1969 |
[Renal regulation of the sodium balance].
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Capillaries; Dogs; Glomerular Filtration Rate; He | 1971 |
Salt, water and adrenal steroid metabolism.
Topics: Adrenal Cortex Hormones; Aldosterone; Animals; Ascites; Corticosterone; Diet, Sodium-Restricted; Dog | 1964 |
Plasma renin concentration in human hypertension.
Topics: Aldosterone; Female; Heart Failure; Humans; Hypertension; Hypertension, Malignant; Kidney Failure, C | 1967 |
31 trials available for aldosterone and Chronic Kidney Failure
| Article | Year |
|---|---|
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.
Topics: Adult; Aged; Aldosterone; Cardiovascular Diseases; Diastole; Dose-Response Relationship, Drug; Doubl | 2019 |
The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure.
Topics: Adult; Albuminuria; Aldosterone; Allografts; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Bi | 2014 |
25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Topics: Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors | 2013 |
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
Topics: Adolescent; Adult; Albuminuria; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Co | 2014 |
Development of hypertension and effects of benazepril hydrochloride in a canine remnant kidney model of chronic renal failure.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Benzazepines; Blood Pr | 2008 |
Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aged; Aged, 80 and over; Aldosterone; Biomarkers; Blood | 2009 |
Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Press | 2002 |
The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Female; Humans; H | 2010 |
Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
Topics: Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; C | 2010 |
Olmesartan medoxomil treatment is associated with decreased plasma B-type natriuretic peptide levels in patients on hemodialysis.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Female; Humans; Hyper | 2012 |
Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease.
Topics: Aldosterone; Confidence Intervals; Double-Blind Method; Eplerenone; Female; Health Status Indicators | 2012 |
Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis.
Topics: Adult; Aged; Aldosterone; Blood Glucose; Epinephrine; Fludrocortisone; Humans; Hyperkalemia; Insulin | 2002 |
Is spironolactone safe for dialysis patients?
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Hyperkalemia; Kidney Failure, Chronic; | 2003 |
Safety of low-dose spironolactone administration in chronic haemodialysis patients.
Topics: Adult; Aged; Aldosterone; Canrenone; Humans; Hyperkalemia; Kidney Failure, Chronic; Middle Aged; Min | 2003 |
Effect of spironolactone on K(+) homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients.
Topics: Adolescent; Adult; Aged; Aldosterone; Dietary Carbohydrates; Epithelial Sodium Channels; Female; Hom | 2004 |
Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.
Topics: Adult; Aldosterone; Antihypertensive Agents; Anuria; Blood Pressure; Body Weight; Cross-Over Studies | 2005 |
Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment.
Topics: Aldosterone; Blood Pressure; Body Weight; Diuretics; Hemodynamics; Humans; Hypertension; Indapamide; | 1983 |
[Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
Topics: Adult; Aged; Aldosterone; Calcium Channel Blockers; Electrolytes; Female; Heart Rate; Humans; Hydroc | 1984 |
C-type natriuretic peptide in chronic renal failure and its action in humans.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Diuresis; Humans; Injections, I | 1996 |
Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; | 1997 |
A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium.
Topics: Adult; Aged; Aldosterone; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Drug Admin | 1999 |
Pharmacokinetics and blood pressure response of losartan in end-stage renal disease.
Topics: Adult; Aldosterone; Antihypertensive Agents; Area Under Curve; Blood Pressure; Female; Half-Life; Hu | 2000 |
Add-on angiotensin receptor blockade with maximized ACE inhibition.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin Receptor Antagonists; Angiotens | 2001 |
Nonselective Beta-adrenergic blockade augments fasting hyperkalemia in hemodialysis patients.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Glucose; Blood Pressure; Fasting; Female; Hum | 2002 |
Renal acidification in patients with mineralocorticoid deficiency.
Topics: Acid-Base Equilibrium; Acidosis; Addison Disease; Adrenalectomy; Adult; Aged; Aldosterone; Bicarbona | 1976 |
Effects of atrial natriuretic peptide infusion and its metabolism in patients with chronic renal failure.
Topics: Adrenal Glands; Adult; Aged; Aged, 80 and over; Aldosterone; Atrial Natriuretic Factor; Blood Pressu | 1991 |
Glomerular and hormonal responses to dietary protein intake in human renal disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Blood Proteins; Dextrans; Diabetic Nephropathies; | 1987 |
Effects of WY 47987 (atrial natriuretic factor 102-126) in patients with renal insufficiency: a placebo-controlled, randomised study.
Topics: Aldosterone; Atrial Natriuretic Factor; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle | 1989 |
Hypertensive dysregulation and its modification by calcium channel blockade in nonoliguric renal failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Calcium Channel Blockers; Catecholamines; | 1989 |
Inducing hyperkalemia by converting enzyme inhibitors and heparin.
Topics: Acidosis; Acute Kidney Injury; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, | 1988 |
Acute renal effects of sulindac and indomethacin in chronic renal failure.
Topics: Acetylglucosaminidase; Administration, Oral; Adult; Aged; Aldosterone; beta 2-Microglobulin; Creatin | 1985 |
255 other studies available for aldosterone and Chronic Kidney Failure
| Article | Year |
|---|---|
High cortisol levels are associated with oxidative stress and mortality in maintenance hemodialysis patients.
Topics: Aldosterone; Biomarkers; Cohort Studies; Female; Humans; Hydrocortisone; Kidney Failure, Chronic; Ma | 2022 |
Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.
Topics: Acid-Base Equilibrium; Acidosis; Adaptation, Physiological; Aldosterone; Angiotensin II; Biomarkers; | 2020 |
Mineralocorticoid Receptor Antagonists in ESKD.
Topics: Aldosterone; Cardiovascular Diseases; Eplerenone; Humans; Kidney Failure, Chronic; Mineralocorticoid | 2020 |
Aldosterone and Insulin Resistance: Vicious Combination in Patients on Maintenance Hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Cohort Studies; Cross-Sectional Studies; Female; Humans | 2018 |
Plasma marinobufagenin immunoreactivity in patients with chronic kidney disease: a case control study.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Bufanolides; Female; Glom | 2018 |
Clinical and neurohumoral associates of variations in plasma Na
Topics: Adult; Age Factors; Aged; Aldosterone; Biomarkers; Blood Glucose; Cohort Studies; Female; Follow-Up | 2019 |
Effect of early stage kidney disease on cardiac mass: comparison to post-donation renal function.
Topics: Adolescent; Adult; Aged; Aldosterone; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Echo | 2013 |
Adrenocortical function in hypotensive patients with end stage renal disease.
Topics: Adrenal Cortex; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hypotension; Kidney Failure, Chr | 2014 |
Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Topics: Aged; Aldosterone; Black People; Cardiovascular Diseases; Female; Follow-Up Studies; Glomerular Filt | 2014 |
Aldosterone, mortality, cardiovascular events and reverse epidemiology in end stage renal disease.
Topics: Aged; Aldosterone; Biomarkers; Cardiovascular Diseases; Female; Heart Atria; Humans; Kaplan-Meier Es | 2015 |
Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.
Topics: Aldosterone; Humans; Hypertension; Kidney Failure, Chronic; Mineralocorticoid Receptor Antagonists; | 2016 |
Cardiac benefits of mineralocorticoid receptor inhibition in renal failure.
Topics: Aldosterone; Animals; Cohort Studies; Disease Models, Animal; Humans; Hypertrophy, Left Ventricular; | 2008 |
Effect of spironolactone on hypertrophy of left ventricular myocardium in wistar rats with experimental uremia.
Topics: Aldosterone; Animals; Creatinine; Electrolytes; Hypertrophy, Left Ventricular; Kidney Failure, Chron | 2008 |
Association of (pro)renin receptor mRNA expression with angiotensin-converting enzyme mRNA expression in human artery.
Topics: Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors | 2009 |
Disordered aldosterone-volume relationship in end-stage kidney disease.
Topics: Adolescent; Adult; Aged; Aldosterone; C-Reactive Protein; Child; Electric Impedance; Extracellular S | 2009 |
Role of 11beta-hydroxysteroid dehydrogenase 2 renal activity in potassium homeostasis in rats with chronic renal failure.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Animals; Blood Pressure; Homeostasis; Kidn | 2010 |
[A case of aldosterone-producing adenoma associated with end-stage renal disease].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Female; Humans; Kidney Failure, Chronic; Middle Aged; | 2010 |
Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Aldosterone; Diuretics; Female; Furosemide; Heart Failure; Hemofiltration; | 2010 |
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2010 |
A multi-marker approach to predict incident CKD and microalbuminuria.
Topics: Aged; Albuminuria; Aldosterone; Biomarkers; C-Reactive Protein; Causality; Cohort Studies; Comorbidi | 2010 |
Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone.
Topics: Aldosterone; Double-Blind Method; Endothelins; Glomerular Filtration Rate; Humans; Kidney; Kidney Fa | 2011 |
[The role of aldosterone in uremic vascular calcification in patient with end-stage renal disease].
Topics: Aldosterone; Humans; Kidney Failure, Chronic; Uremia; Vascular Calcification | 2010 |
Association of plasma renin activity and aldosterone-renin ratio with prevalence of chronic kidney disease: the Kaiser Permanente Southern California cohort.
Topics: Adult; Aged; Aldosterone; California; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studi | 2011 |
Assessing acid retention.
Topics: Aldosterone; Endothelins; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Sodiu | 2011 |
Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study.
Topics: Aldosterone; Biomarkers; Comorbidity; Creatinine; Female; Follow-Up Studies; Glomerular Filtration R | 2012 |
Aldosterone blockade: the heart versus the kidney.
Topics: Aldosterone; Animals; Humans; Kidney; Kidney Failure, Chronic; Mineralocorticoid Receptor Antagonist | 2012 |
A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension.
Topics: Adult; Aged; Aldosterone; Amino Acid Sequence; Biomarkers; Black People; Female; Genetic Predisposit | 2003 |
The clinical significance of aldosterone in ESRD: Part II.
Topics: Aldosterone; Arteriosclerosis; Endothelium, Vascular; Humans; Kidney Failure, Chronic; Risk Factors | 2004 |
[Hyperkalemia in the chronic renal failure: is it always the aldosterone the responsible?].
Topics: Aldosterone; Humans; Hyperkalemia; Kidney Failure, Chronic; Potassium | 1982 |
Adrenal aldosterone biosynthesis is elevated in a model of chronic renal failure--role of local adrenal renin-angiotensin system.
Topics: Adrenal Glands; Aldosterone; Animals; Kidney; Kidney Failure, Chronic; Male; Rats; Rats, Sprague-Daw | 2004 |
Effect of oral glucose administration on serum potassium concentration in hemodialysis patients.
Topics: Administration, Oral; Adult; Aged; Aldosterone; Blood Glucose; Epinephrine; Extracellular Fluid; Fem | 2005 |
N-acetylcysteine attenuates the progression of chronic renal failure.
Topics: Acetylcysteine; Aldosterone; Animals; Antioxidants; Drug Therapy, Combination; Glomerular Filtration | 2005 |
Is it time for spironolactone therapy in dialysis patients?
Topics: Aldosterone; Humans; Kidney Failure, Chronic; Mineralocorticoid Receptor Antagonists; Renal Dialysis | 2006 |
Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Aquaporin 2; Benzim | 2007 |
Plasma aldosterone: comparison of a new automated assay with a standard extraction method.
Topics: Aldosterone; Automation; Blood Chemical Analysis; Diagnostic Errors; Edetic Acid; Humans; Kidney Fai | 2006 |
Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors.
Topics: Adipocytes; Adrenal Glands; Aldosterone; Animals; Cyclic N-Oxides; Disease Models, Animal; Eplerenon | 2006 |
Primary hyperaldosteronism in a patient with end-stage renal disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Follow-Up Studies; Fosinopril | 2007 |
Aldosterone antagonists: silver bullet or just sodium excretion and potassium retention?
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Huma | 2007 |
Role of aldosterone in left ventricular hypertrophy among African-American patients with end-stage renal disease on hemodialysis.
Topics: Aged; Aldosterone; Black or African American; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, | 2007 |
Hypertension associated with large bilateral adrenal masses.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Carcinoma; Catecholamines; Dia | 2007 |
Usual ACE inhibitor therapy in CKD patients is associated with lower plasma aldosterone levels than usual angiotensin receptor blocker therapy.
Topics: Adult; Aged; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors | 2007 |
Associations between sympathetic activity, plasma concentrations of renin, aldosterone, and parathyroid hormone, and the degree of intractability of blood pressure control in modialysis patients.
Topics: Adult; Aged; Aldosterone; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Epinephrine | 2007 |
The contribution of nutrition to the protective value of high plasma aldosterone concentrations in hemodialysis patients.
Topics: Aldosterone; Humans; Kidney Failure, Chronic; Nutritional Status; Renal Dialysis | 2007 |
Diagnostic value of salivary cortisol in end stage renal disease.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aldosterone; Biomarkers; Humans; Hydrocortisone; | 2008 |
Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Femal | 1984 |
Significance of the renin-angiotensin system for blood pressure regulation in end-stage renal disease.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine V | 1984 |
The effect of hemodialysis on levels of cyclic nucleotide-associated hormones in patients with chronic renal failure.
Topics: Aldosterone; Catecholamines; Cyclic AMP; Cyclic GMP; Female; Hormones; Humans; Insulin; Kidney Failu | 1980 |
Endocrine disorders in chronic hemodialysis patients (with the exclusion of hyperparathyroidism).
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensins; Carbohydrate Metabolism; Catecholamines; End | 1981 |
Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood P | 1982 |
Preservation of normal adrenal androgen secretion in end stage renal disease.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Androgens; Androstenedione; Dehydro | 1982 |
Sodium homeostasis in chronic renal disease.
Topics: Aldosterone; Blood Proteins; Chronic Disease; Diet, Sodium-Restricted; Glomerular Filtration Rate; G | 1982 |
Effects of angiotensin III and ACTH on aldosterone secretion.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Angiotensin III; Dexamethasone; Electrolyt | 1982 |
Hormonal responses to acute volume changes in anephric subjects.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aldosterone; Blood Pressure | 1983 |
Plasma 18-hydroxycorticosterone during continuous ambulatory peritoneal dialysis.
Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Aldosterone; Corticosterone; Dose-Response Re | 1983 |
Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.
Topics: Adult; Aged; Aldosterone; Atenolol; Female; Humans; Insulin; Kidney Failure, Chronic; Male; Middle A | 1983 |
[Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure].
Topics: Aldosterone; Bicarbonates; Humans; Kidney Failure, Chronic; Peptidyl-Dipeptidase A; Renal Dialysis; | 1983 |
Renal kallikrein and PGE in the exaggerated fractional Na excretion in patients with chronic renal failure.
Topics: Adult; Aldosterone; Blood Pressure; Humans; Kallikreins; Kidney Failure, Chronic; Male; Natriuresis; | 1983 |
Amelioration of metabolic acidosis by dietary potassium restriction in hyperkalemic patients with chronic renal insufficiency.
Topics: Acidosis, Renal Tubular; Aged; Aldosterone; Ammonia; Humans; Hydrogen-Ion Concentration; Hyperkalemi | 1984 |
Vasoactive hormones in children with chronic renal failure.
Topics: Adolescent; Aldosterone; Arginine Vasopressin; Blood Pressure; Child; Epinephrine; Female; Heart Rat | 1983 |
The renin-angiotensin-aldosterone system in fulminant hepatic failure.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Creatinine; Female; Homeostasis; Humans; Kidney | 1983 |
Relation between plasma aldosterone concentration and renal handling of sodium and potassium, in particular in patients with chronic renal failure.
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Hyperkalemia; Hypokalemia; Kidney Failure, Chronic; | 1984 |
Hyporeninemic hypoaldosteronism in a patient with multiple myeloma.
Topics: Acidosis; Aldosterone; Humans; Hyperkalemia; Kidney Failure, Chronic; Kidney Neoplasms; Male; Middle | 1984 |
The syndrome of hyporeninemic hypoaldosteronism.
Topics: Aged; Aldosterone; Female; Humans; Hyperkalemia; Kidney Failure, Chronic; Male; Middle Aged; Renin; | 1984 |
Blunted kaliuresis after an acute potassium load in patients with chronic renal failure.
Topics: Adult; Aged; Aldosterone; Creatinine; Homeostasis; Humans; Kidney Failure, Chronic; Middle Aged; Pot | 1983 |
Role of renal prostaglandin E2 in chronic renal disease hypertension.
Topics: Adolescent; Adult; Aldosterone; Dinoprostone; Female; Humans; Hypertension, Renal; Indomethacin; Kid | 1982 |
Diurnal variation of urinary potassium excretion in chronic renal insufficiency.
Topics: Adult; Aged; Aldosterone; Circadian Rhythm; Creatinine; Female; Hematocrit; Humans; Hydrogen-Ion Con | 1982 |
Renin-angiotensin-aldosterone system in arterial hypertension.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Fa | 1980 |
The renin-aldosterone system in secondary hypertension: relationship to blood pressure and plasma electrolytes.
Topics: Aldosterone; Blood Pressure; Electrolytes; Humans; Hyperaldosteronism; Hypertension; Kidney Failure, | 1980 |
Hyporeninemic hypoaldosteronism. An overlooked cause of hyperkalemia.
Topics: Adult; Aged; Aldosterone; Female; Humans; Hyperkalemia; Kidney Failure, Chronic; Male; Middle Aged; | 1981 |
Response of plasma aldosterone to sequential ultrafiltration, dialysis and conventional hemodialysis.
Topics: Adult; Aldosterone; Blood; Blood Pressure; Blood Proteins; Female; Humans; Kidney Failure, Chronic; | 1980 |
[The regulation of plasma aldosterone in hemodialysis patients].
Topics: Adult; Aldosterone; Humans; Hydrocortisone; Kidney Failure, Chronic; Potassium; Renal Dialysis; Reni | 1980 |
[The renin-angiotensin-aldosterone system under stimulation conditions after kidney transplantation].
Topics: Adult; Aldosterone; Angiotensin II; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Ki | 1981 |
[Chronic ambulatory peritoneal dialysis].
Topics: Adult; Aged; Aldosterone; Blood Pressure; Calcium; Cholesterol; Creatinine; Hematocrit; Humans; Kidn | 1981 |
Renin, aldosterone and other mineralocorticoids in hyperkalemic patients with chronic renal failure showing mild azotemia.
Topics: 18-Hydroxycorticosterone; Adult; Aldosterone; Corticosterone; Desoxycorticosterone; Female; Humans; | 1981 |
Glucose-induced paradoxical increase in HGH with potentiated decrease in serum potassium in chronic renal failure.
Topics: Aged; Aldosterone; Female; Glucose; Growth Hormone; Humans; Insulin; Kidney Failure, Chronic; Kineti | 1982 |
Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients.
Topics: Adult; Aged; Aldosterone; Bradykinin; Captopril; Female; Humans; Hypertension; Hypertension, Maligna | 1981 |
Plasma aldosterone concentrations in chronic renal disease.
Topics: Adult; Aldosterone; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Renin | 1982 |
[A case of mild renal failure, who showed persistent hyperkalemia and hyperchloremic acidosis without aldosterone deficiency--genesis of acidosis (author's transl)].
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Chlorides; Humans; Hyperkalemia; Kidney Failure, Chroni | 1982 |
[Study of the hemodynamics of patients with symptomatic renal hypertension].
Topics: Adult; Aldosterone; Chronic Disease; Female; Glomerulonephritis; Hemodynamics; Humans; Hypertension, | 1982 |
[Physiopathology and therapy of the ascites in liver cirrhosis].
Topics: Aldosterone; Ascites; Diet, Sodium-Restricted; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Sod | 1982 |
[A case for discussion: hyperkalemia in a 64-year old patient].
Topics: Aldosterone; Diabetic Nephropathies; Diagnosis, Differential; Female; Humans; Hyperkalemia; Kidney F | 1982 |
[Role of aldosterone in the potassium excretion in patients with advanced chronic renal failure (author's transl)].
Topics: Adult; Aldosterone; Feces; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Potassium | 1981 |
[Relationship between vasoactive substances and changes in blood pressure during hemodialysis].
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Dopamine; Female; Humans; Kidney Failure, Ch | 1995 |
The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Female; Glomerulonephritis; Humans; H | 1994 |
Urinary prostaglandins (PGE2 and PGI2) in hyporeninaemic hypoaldosteronism in diabetic patients with chronic renal failure.
Topics: Aldosterone; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dinoprostone; Epoprosten | 1994 |
[Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency].
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Blood Pressure; Cations; Creatinine; Female; Humans; | 1993 |
Response of vasoactive substances to intermittent ultrafiltration in normotensive hemodialysis patients.
Topics: Adult; Aged; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Blood Vol | 1993 |
Treatment and prevention of hyperkalemia in end-stage renal disease.
Topics: Aldosterone; Catecholamines; Humans; Hyperkalemia; Insulin; Kidney Failure, Chronic; Parathyroid Hor | 1993 |
Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients.
Topics: Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Epinephr | 1993 |
Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis.
Topics: Adult; Aldosterone; Female; Humans; Kidney Failure, Chronic; Male; Peptidyl-Dipeptidase A; Renal Dia | 1995 |
A first report: living related kidney transplantation on a patient with Bartter's syndrome.
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Urea Nitrogen; Erythropoietin; Family; G | 1996 |
Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease.
Topics: Adaptation, Physiological; Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Diet, Sodi | 1996 |
Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
Topics: Adult; Aged; Aldosterone; Bicarbonates; Blood Glucose; Drug Combinations; Epinephrine; Female; Gluco | 1996 |
Extrarenal potassium homeostasis with maximal exercise in end-stage renal disease.
Topics: Adult; Aged; Aldosterone; Female; Hemodynamics; Homeostasis; Humans; Hyperkalemia; Insulin; Kidney F | 1996 |
Impact of profile haemodialysis on intra-/extracellular fluid shifts and the release of vasoactive hormones in elderly patients on regular dialysis treatment.
Topics: Aged; Aging; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Coronary Disease; | 1997 |
Pathophysiological role and diuretic efficacy of atrial natriuretic peptide in renal patients.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Chronic Disease; Cyclic GMP; Diet, Sodium-Restricted; | 1997 |
[A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Child, Preschool; Cortisone; Female; Humans; Hyd | 1997 |
[Role of aldosterone in potassium secretion in chronic renal failure associated with hypertension (transtubular potassium gradient)].
Topics: Aldosterone; Antihypertensive Agents; Drug Resistance; Female; Humans; Hyperkalemia; Hypertension, R | 1997 |
Local upregulation of colonic angiotensin II receptors enhances potassium excretion in chronic renal failure.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Colon; Imidazoles; Kidney Fa | 1998 |
Evaluation of plasma osmolality and hormone responses in elderly chronic hemodialysis patients with excessive interdialytic weight gain.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Humans; Kidney Failure, Chronic; Osmolar Conce | 1997 |
Impact of gender on the renal response to angiotensin II.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Estradiol; Female; Glomerular Filtration Rate; H | 1999 |
Neurohumoral responses to a single haemodialysis in chronic renal patients.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Body Weight; Catecholamines; Female; Humans; Ki | 1999 |
Studies on diurnal blood pressure variation in kidney diseases associated with excessive salt and water retention.
Topics: Adult; Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Water; Catecholamine | 1999 |
[Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
Topics: Adult; Aldosterone; Biomarkers; Blood Pressure; Female; Follow-Up Studies; Humans; Hypertension, Ren | 1999 |
Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis.
Topics: Adrenergic alpha-Antagonists; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blo | 1999 |
The unusual patient with advanced renal insufficiency on ACE inhibitors.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Female; Hum | 2000 |
Effect of erythropoietin treatment on blood pressure and intracellular cation concentrations in maintenance hemodialysis patients.
Topics: Aged; Aldosterone; Anemia; Atrial Natriuretic Factor; Blood Pressure; Blood Viscosity; Calcium; Cati | 1996 |
TGF-beta1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man.
Topics: Aldosterone; Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Circadian Rhythm; Disease Models, Animal | 2000 |
Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
Topics: Adult; Aldosterone; Chromatography, High Pressure Liquid; Epinephrine; Female; Humans; Hypertension; | 2001 |
[Bartter's syndrome with hyperuricemia].
Topics: Adult; Aldosterone; Bartter Syndrome; Child; Female; Humans; Hypokalemia; Kidney Failure, Chronic; P | 2001 |
Insulin and mineralocorticoids influence on extrarenal potassium metabolism in chronic hemodialysis patients.
Topics: Aged; Aged, 80 and over; Aldosterone; Female; Fludrocortisone; Glucose; Humans; Insulin; Insulin Sec | 2001 |
Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism.
Topics: Acidosis; Aldosterone; Ammonia; Humans; Hydrogen-Ion Concentration; Hyperkalemia; Ion Exchange Resin | 1976 |
Renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Ammonia; Bicarbonates; Electrolytes; Extracellular Spac | 1977 |
Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism.
Topics: Acidosis, Renal Tubular; Adult; Aged; Aldosterone; Ammonia; Fludrocortisone; Glomerular Filtration R | 1977 |
Pathogenic significance of adrenocortical hormones in essential hypertension.
Topics: 18-Hydroxydesoxycorticosterone; Adrenal Cortex Hormones; Aldosterone; Cortodoxone; Dehydroepiandrost | 1977 |
[Comparative study of plasma levels of renin and aldosterone activity in essential arterial hypertension in relation to duration of the disease and the presence of complications].
Topics: Acute Disease; Adolescent; Adult; Aldosterone; Cardiomegaly; Chronic Disease; Female; Humans; Hypert | 1977 |
Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Catecholamine | 1975 |
Control of aldosterone responsiveness in terminal renal failure.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Female; Heparin; Humans; Kidney Failure, Chro | 1975 |
Aldosterone response to ACTH stimulation in anephric and non-nephrectomized patients on regular hemodialysis.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Dose-Response Relationship, Drug; Female; Humans; H | 1977 |
Hyperkalemia due to selective hypoaldosteronism.
Topics: Acidosis; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Chlorides; Humans; Hyperkalemia; | 1977 |
Lack of effect of prolactin inhibition by alpha-bromoergocriptine (CB 154) on plasma aldosterone in anephric and non-nephrectomized patients on regular haemodialysis.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Bromocriptine; Depression, Chemical; Ergolines; Fem | 1977 |
[Plasma concentration of aldosterone in chronic renal failure during change of position, dialysis, after bilateral nephrectomy and transplantation (author's transl)].
Topics: Aldosterone; Humans; Kidney Failure, Chronic; Kidney Transplantation; Nephrectomy; Posture; Renal Di | 1977 |
[Renin-angiotensin-aldosterone system in chronic renal failure. Part 3) Change of the renin-angiotensin-aldosterone system after bilateral nephrectomy and kidney transplantation in chronic renal failure (author's transl)].
Topics: Adolescent; Adult; Aldosterone; Angiotensins; Female; Humans; Kidney Failure, Chronic; Kidney Transp | 1978 |
[Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Female; Humans; Kidney Failure, Chro | 1979 |
Presence of insulin-renin-aldosterone-potassium interrelationship in normal subjects, disrupted in chronic hemodialysis patients.
Topics: Adult; Aldosterone; Circadian Rhythm; Female; Humans; Insulin; Kidney Failure, Chronic; Male; Potass | 1978 |
Plasma aldosterone during extracellular fluid volume expansion in patients on regular haemodialysis.
Topics: Adult; Aldosterone; Extracellular Space; Female; Humans; Hydrocortisone; Kidney Failure, Chronic; Ma | 1977 |
18-Hydroxy-11-deoxycorticosterone in hypertensive uremic patients during hemodialysis.
Topics: 18-Hydroxydesoxycorticosterone; Adrenal Cortex Hormones; Aged; Aldosterone; Desoxycorticosterone; Fe | 1979 |
beta blockade with pindolol: differential cardiac and renal effects despite similar plasma kinetics in normal and uremic man.
Topics: Adult; Aldosterone; Heart Rate; Humans; Kidney Failure, Chronic; Pindolol; Renal Dialysis; Renin | 1979 |
Regulations of plasma aldosterone in young hyperkalemic patients with stable chronic renal failure.
Topics: Adolescent; Adult; Aldosterone; Diet, Sodium-Restricted; Humans; Hyperkalemia; Kidney Failure, Chron | 1979 |
[Plasma aldosterone in chronic renal insufficiency and in anephric patients (author's transl)].
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrect | 1979 |
[Change of plasma aldosterone concentration before and after hemodialysis (author's transl)].
Topics: Adult; Aldosterone; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Reni | 1979 |
Minoxidil increases aldosterone metabolic clearance in hypertensive patients.
Topics: Adult; Aldosterone; Humans; Hypertension; Kidney Failure, Chronic; Metabolic Clearance Rate; Middle | 1979 |
[Changes in aldosterone level and renin activity of blood of patients on programmed hemodialysis].
Topics: Adult; Aldosterone; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Reni | 1979 |
[Clinical and experimental studies of plasma and urinary aldosterone determination].
Topics: Adult; Aged; Aldosterone; Evaluation Studies as Topic; Female; Humans; Hyperaldosteronism; Hypertens | 1977 |
Dissociation of the diurnal variation of aldosterone and cortisol in anephric subjects.
Topics: Adult; Aldosterone; Cation Exchange Resins; Circadian Rhythm; Female; Humans; Hydrocortisone; Kidney | 1979 |
Metabolic alkalosis.
Topics: Acid-Base Equilibrium; Aldosterone; Alkalosis; Bicarbonates; Carbon Dioxide; Diagnosis, Differential | 1977 |
Syndrome of hyporeninemic hypoaldosteronism. Study of two cases and review of the literature.
Topics: Aldosterone; Cryoglobulins; Heart Failure; Humans; Hyperkalemia; Immunoglobulin G; Immunoglobulin M; | 1977 |
Competitive effects of hypokalemia and volume depletion on plasma renin activity, aldosterone and catecholamine concentrations in hemodialysis patients.
Topics: Aldosterone; Blood Pressure; Blood Volume; Catecholamines; Heart Rate; Humans; Hypokalemia; Kidney F | 1977 |
[Hyperkalemic, hyperchloremic acidosis in moderate chronic renal insufficiency and selective hypoaldosteronism].
Topics: Acidosis; Adult; Aged; Aldosterone; Chlorides; Female; Humans; Hyperkalemia; Hypertension; Kidney Fa | 1977 |
[Renin-angiotensin-aldosterone system in chronic renal failure. Part 2) change of renin-angiotensin-aldosterone system during hemodialysis (author's transl)].
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Female; Humans; Kidney Failure, Chronic; Male; Middl | 1977 |
Use of diuretics in treatment of hypertension secondary to renal disease.
Topics: Adult; Aldosterone; Antihypertensive Agents; Creatinine; Female; Furosemide; Humans; Hydrochlorothia | 1978 |
Role of aldosterone in the control of sodium excretion in patients with advanced chronic renal failure.
Topics: Adult; Aldosterone; Body Weight; Creatinine; Diet; Female; Humans; Kidney Failure, Chronic; Male; Mi | 1978 |
Control of plasma aldosterone in terminal renal failure before and after nephrectomy and after renal transplantation.
Topics: Aldosterone; Circadian Rhythm; Humans; Hydrocortisone; Kidney Failure, Chronic; Kidney Transplantati | 1976 |
[Proceedings: Effects of dialysis and dialysis-dependent changes in water-electrolyte balance, on plasma aldosterone in terminal patients with kidney insufficiency].
Topics: Aldosterone; Humans; Kidney Failure, Chronic; Renal Dialysis; Terminal Care; Water-Electrolyte Balan | 1975 |
Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
Topics: Aldosterone; Blood Pressure; Body Weight; Humans; Hydrocortisone; Kidney Failure, Chronic; Potassium | 1977 |
The treatment of the hepatorenal syndrome with intra-renal administration of prostaglandin E1.
Topics: Adult; Aldosterone; Catheterization; Diuresis; Humans; Injections, Intra-Arterial; Kidney Failure, C | 1977 |
Potassium homeostasis in renal failure.
Topics: Acid-Base Equilibrium; Acute Kidney Injury; Aldosterone; Animals; Arginine; Digestive System; Dogs; | 1977 |
[Hypertension in chronic kidney insufficiency in childhood. Significance of renin, aldosterone and blood volume].
Topics: Adolescent; Age Factors; Aldosterone; Blood Volume; Child; Child, Preschool; Humans; Hypertension, R | 1977 |
Prolactinemia during hemodialysis: lack of correlation with sodium, potassium and renin-aldosterone system.
Topics: Aldosterone; Body Weight; Electrolytes; Humans; Kidney Failure, Chronic; Male; Nephrectomy; Potassiu | 1977 |
Plasma renin activity and plasma aldosterone level in patients with chronic renal failure on maintenance haemodialysis.
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Di | 1976 |
Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Topics: Acidosis, Renal Tubular; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Cushing Synd | 1976 |
The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Diet; Humans; Hyperaldosteronism; Hypertension; Kidney | 1976 |
The control of aldosterone in anephric man.
Topics: Aldosterone; Humans; Kidney Failure, Chronic; Nephrectomy | 1976 |
Relationships of the renin-angiotensin-aldosterone system and sodium balance to blood pressure regulation in chronic renal failure of polycystic kidney disease.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Body Water; Creatinine; Extracellular Space; Fem | 1975 |
[Changes in plasma aldosterone during hemodialysis in patients with terminal kidney insufficiency].
Topics: Aldosterone; Female; Humans; Kidney Failure, Chronic; Male; Potassium; Renal Dialysis; Sodium | 1975 |
The kidney in congestive heart failure.
Topics: Aldosterone; Angiotensin II; Heart Failure; Hematuria; Humans; Kidney; Kidney Failure, Chronic; Natr | 1975 |
[Effect of dialysis and dialysis-dependent changes in water-electrolyte balance on plasma aldosterone in patients with terminal kidney failure].
Topics: Aldosterone; Humans; Kidney Failure, Chronic; Renal Dialysis; Terminal Care; Water-Electrolyte Balan | 1975 |
[Plasma aldosterone during haemodialysis in patients with terminal renal failure].
Topics: Aldosterone; Humans; Kidney Failure, Chronic; Potassium; Renal Dialysis | 1976 |
[The relationship between plasma atrial natriuretic peptide (ANP) and glomerular ANP receptors in 5/6 nephrectomized rats].
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Kidney; Kidney Failure, Chronic; Ma | 1992 |
[Piretanide. Effect on renal hemodynamics, its hormonal regulation and renal prostaglandin metabolism in pre-terminal renal failure].
Topics: Aldosterone; Atrial Natriuretic Factor; Diuretics; Humans; Kidney; Kidney Failure, Chronic; Kidney F | 1992 |
[Do patients with chronic kidney failure need cardiac glycosides?].
Topics: Aldosterone; Cardiac Glycosides; Drug Evaluation; Female; Hemodynamics; Humans; Kidney Failure, Chro | 1992 |
Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia.
Topics: Acute Disease; Adrenal Glands; Aldosterone; Epinephrine; Humans; Hyperkalemia; Kidney Failure, Chron | 1992 |
Diltiazem enhances potassium disposal in subjects with end-stage renal disease.
Topics: Adolescent; Adult; Aldosterone; Blood Glucose; Circadian Rhythm; Diltiazem; Female; Humans; Hydrocor | 1992 |
Plasma levels of brain natriuretic peptide in patients with cirrhosis.
Topics: Alanine Transaminase; Aldosterone; Alkaline Phosphatase; Ascites; Aspartate Aminotransferases; Bilir | 1992 |
Acute effect of erythropoietin on plasma renin activity and aldosterone levels in end-stage renal disease.
Topics: Aldosterone; Blood Pressure; Erythropoietin; Humans; Hypertension; Kidney Failure, Chronic; Renin; V | 1992 |
Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Humans; Hypertension; Kidney Failure, | 1991 |
Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Female; Fosinopril; Humans; Kidn | 1991 |
Increase in urinary kallikrein excretion following hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Kallikreins; Kidney Failure, Chronic; M | 1991 |
Angiotensin-converting enzyme inhibitor and anemia in a patient undergoing hemodialysis.
Topics: Aldosterone; Anemia; Blood Pressure; Enalapril; Erythropoietin; Hematocrit; Humans; Hypertension; Ki | 1991 |
The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Adult; Aged; Aldos | 1990 |
Atrial natriuretic factor and changes in dietary sodium intake in patients with chronic renal failure.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Creatine; Cyclic GMP; Enalapril; Female; Humans | 1990 |
Water immersion induced alterations of plasma vasopressin levels and activity of the renin-angiotensin-aldosterone system in noninflammatory acute renal failure and end-stage renal failure.
Topics: Acute Kidney Injury; Adult; Aldosterone; Arginine Vasopressin; Humans; Immersion; Kidney Failure, Ch | 1990 |
[The malignant hypertension syndrome: incontrovertible and questionable truths].
Topics: Aldosterone; Biopsy, Needle; Chronic Disease; Glomerulonephritis; Hemodynamics; Humans; Hydrocortiso | 1990 |
Regulation of plasma aldosterone during hemodialysis.
Topics: Acetates; Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Bicarbonates; Dialysis Solutions; Hu | 1990 |
Aldosterone response to insulin-induced hypoglycemia in hemodialysis patients.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Blood Glucose; Hemofiltration; Humans; Hydroc | 1989 |
Falsely elevated plasma aldosterone concentration by direct radioimmunoassay in chronic renal failure.
Topics: Aldosterone; Creatinine; False Positive Reactions; Humans; Kidney Failure, Chronic; Middle Aged; Rad | 1989 |
Impairment of beta 2-adrenoceptor-stimulated potassium uptake in end-stage renal disease.
Topics: Adult; Aldosterone; Blood Glucose; Carbon Dioxide; Female; Humans; Hydrogen-Ion Concentration; Insul | 1987 |
Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs).
Topics: Adult; Aged; Aldosterone; Female; Furosemide; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pe | 1987 |
Studies on the secretion, metabolism and action of atrial natriuretic peptide in man.
Topics: Aldosterone; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Cardiac Pacing, Artificial; Chromatogr | 1986 |
Atrial natriuretic factor in mild to moderate chronic renal failure.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerular Filtration R | 1988 |
Radioimmunoassay of atrial natriuretic peptide in human plasma: application to studies of volume and blood pressure homeostasis.
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Electrolytes; Extracellular Space; Heart Fai | 1988 |
Cardiac function and cardiovascular hormone balance during hemodialysis with special reference to atrial natriuretic peptide.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Cardiomegaly; Echocardiography; Female; Heart; | 1988 |
Sodium potassium ATPase activity in human rectal mucosa with and without renal insufficiency.
Topics: Adenosine Triphosphatases; Aldosterone; Animals; Ca(2+) Mg(2+)-ATPase; Creatinine; Humans; Intestina | 1985 |
Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure.
Topics: Adolescent; Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Creatini | 1985 |
[Changes in the activity of plasma renin and blood aldosterone and in that of the enzyme converting angiotensin I to angiotensin II during the dialytic treatment of patients with chronic renal insufficiency].
Topics: Adult; Aged; Aldosterone; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peptidyl-Dipep | 1985 |
[Mechanisms of hypertension in patients with terminal kidney failure on programmed hemodialysis].
Topics: Adult; Aldosterone; Blood Pressure; Humans; Hypertension; Kidney Failure, Chronic; Peptidyl-Dipeptid | 1986 |
[Clinical pharmacology of enalapril in hypertension with chronic renal failure].
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Heart Rate; Humans | 1986 |
Lisinopril in hypertensive patients with and without renal failure.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Enal | 1987 |
Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients.
Topics: Aldosterone; Arginine Vasopressin; Diuretics; Electrolytes; Epinephrine; Furosemide; Heart Failure; | 1988 |
Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
Topics: Adult; Aged; Aldosterone; Bicarbonates; Blood Glucose; Epinephrine; Female; Humans; Hyperkalemia; In | 1988 |
Dietary protein restriction lessens the glomerular permselective defect in human renal disease.
Topics: Aldosterone; Dietary Proteins; Humans; Kidney Failure, Chronic; Kidney Glomerulus; Prostaglandins; R | 1988 |
Effect of water immersion on plasma renin activity and aldosteronaemia in chronic renal failure.
Topics: Adult; Aldosterone; Blood Pressure; Body Weight; Humans; Immersion; Kidney Failure, Chronic; Plasma | 1988 |
Dopamine control of aldosterone secretion in end-stage renal failure.
Topics: Adult; Aldosterone; Dopamine; Female; Humans; Kidney Failure, Chronic; Lisuride; Male; Metoclopramid | 1986 |
Effects of heparin-induced aldosterone deficiency on renal function in patients with chronic glomerulonephritis.
Topics: Aldosterone; Blood Pressure; Glomerular Filtration Rate; Glomerulonephritis; Heparin; Humans; Hypera | 1987 |
The renin-angiotensin-aldosterone system during haemodialysis with acetate or bicarbonate at different dialysate sodium concentrations.
Topics: Acetates; Adult; Aldosterone; Angiotensin II; Bicarbonates; Female; Humans; Kidney Failure, Chronic; | 1987 |
Reduced angiotensin II induced vascular reactivity in chronic renal failure.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Calcium; Epinephrine; Fe | 1988 |
Suppression of plasma renin activity by cyclosporine.
Topics: 6-Ketoprostaglandin F1 alpha; Aldosterone; Azathioprine; Creatinine; Cyclosporins; Depression, Chemi | 1987 |
Aldosterone responsiveness to an acute potassium load in diabetes mellitus and chronic renal insufficiency.
Topics: Aldosterone; Diabetes Mellitus; Female; Humans; Kidney Failure, Chronic; Male; Potassium; Renin | 1987 |
Increased levels of plasma renin, aldosterone, catecholamines and vasopressin in chronic ambulatory peritoneal dialysis (CAPD) patients.
Topics: Aldosterone; Blood Urea Nitrogen; Creatinine; Electrolytes; Epinephrine; Hematocrit; Humans; Kidney | 1987 |
Chronic effects of oral sulindac on renal haemodynamics and hormones in subjects with chronic renal disease.
Topics: Adult; Aged; Aldosterone; Dinoprostone; Female; Hemodynamics; Humans; Indenes; Kidney; Kidney Failur | 1986 |
Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aldosterone; Blood Pressure; Calcium; Epoprostenol; Femal | 1986 |
[Study of plasma aldosterone in patients on chronic hemodialysis].
Topics: Adult; Aldosterone; Blood Pressure; Humans; Kidney Failure, Chronic; Renal Dialysis; Renin | 1986 |
Corticosterone methyloxidase II activity during hemodialysis.
Topics: Aldosterone; Body Weight; Corticosterone; Cytochrome P-450 CYP11B2; Desoxycorticosterone; Female; Hu | 1987 |
Hyperkalemic left bundle branch block and hyporeninemic hypoaldosteronism (hyperkalemic left bundle branch block).
Topics: Aged; Aldosterone; Bundle-Branch Block; Diagnosis, Differential; Female; Humans; Hyperkalemia; Kidne | 1986 |
The renin-angiotensin-aldosterone system in patients with chronic primary glomerular diseases.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Glomerulonephritis; Humans; Kidney Failure, Ch | 1986 |
Augmented aldosterone and insulin responses to potassium infusion in dogs with renal failure.
Topics: Administration, Oral; Aldosterone; Animals; Diet Therapy; Dogs; Female; Infusions, Intravenous; Insu | 1986 |
Effect of high-dose aldosterone infusions on renal electrolyte excretion in patients with renal insufficiency.
Topics: Adult; Aged; Aldosterone; Chlorides; Electrolytes; Female; Humans; Hydrogen-Ion Concentration; Kidne | 1987 |
Renin-angiotensin-aldosterone system in patients on maintenance hemodialysis.
Topics: Aldosterone; Humans; Kidney Failure, Chronic; Renal Dialysis; Renin-Angiotensin System | 1987 |
Effect of dopaminergic blockade on plasma aldosterone in acquired hypoaldosteronism.
Topics: Adult; Aldosterone; Dopamine Antagonists; Humans; Hyperkalemia; Hypoaldosteronism; Kidney Failure, C | 1987 |
Increased secretion of potassium in the rectum of humans with chronic renal failure.
Topics: Aldosterone; Biological Transport; Dialysis; Diarrhea; Humans; Kidney Failure, Chronic; Potassium; R | 1986 |
Enhanced rectal potassium secretion in chronic renal insufficiency: evidence for large intestinal potassium adaptation in man.
Topics: Adult; Aged; Aldosterone; Amiloride; Creatinine; Dialysis; Female; Humans; Intestinal Absorption; In | 1986 |
Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Female; Hemodynamics; Humans; Hypotension; | 1986 |
Effect of haemodialysis on plasma ADH levels, plasma renin activity and plasma aldosterone levels in patients with end-stage renal disease.
Topics: Adolescent; Adult; Aged; Aldosterone; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Os | 1985 |
The role of urinary kininogen in the regulation of kinin generation.
Topics: Aldosterone; Blood Pressure; Creatinine; Diuresis; Humans; Hypertension; Kallikreins; Kidney Failure | 1985 |
Malignant hypertension in end-stage renal failure: hemodynamic and hormone status.
Topics: Aldosterone; Arginine Vasopressin; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Humans; | 1985 |
Demeclocycline-induced natriuresis and renal insufficiency: in vivo and in vitro studies.
Topics: Administration, Oral; Aldosterone; Animals; Anura; Biological Transport; Blood Urea Nitrogen; Body W | 1985 |
Potassium-aldosterone response in dogs with chronic renal insufficiency.
Topics: Aldosterone; Animals; Disease Models, Animal; Dogs; Female; Glomerular Filtration Rate; Kidney Failu | 1985 |
[Pseudohypoaldosteronism associated with chronic interstitial nephropathy].
Topics: Aldosterone; Female; Humans; Hyperkalemia; Hyponatremia; Kidney Failure, Chronic; Middle Aged; Nephr | 1985 |
Renal failure and hyperchloraemic acidosis.
Topics: Acidosis; Adrenal Insufficiency; Aldosterone; Animals; Azo Compounds; Chlorides; Dogs; Humans; Kidne | 1972 |
Editorial: Sodium and the pressor role of angiotensin.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Hypertension, | 1973 |
Plasma-renin and aldosterone secretion in hypertensive patients with renal or renal artery lesions.
Topics: Adult; Aged; Aldosterone; Angiography; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; | 1965 |
Aldosterone deficiency in chronic renal failure.
Topics: Adrenal Insufficiency; Aged; Aldosterone; Angiotensin II; Diet; Fludrocortisone; Humans; Hyperkalemi | 1968 |
[Does the recent knowledge on the renin-angiotensin system have clinical applications?].
Topics: Aldosterone; Angiotensin II; Blood Pressure; Feedback; Humans; Hyperaldosteronism; Hypertension; Jux | 1968 |
[Secondary hyperaldosteronisms].
Topics: Aldosterone; Angiotensin II; Heart Failure; Hyperaldosteronism; Hyperkalemia; Hypertension, Malignan | 1969 |
[Physiopathology of renovascular hypertension].
Topics: Aldosterone; Angiotensin II; Creatinine; Humans; Hyperaldosteronism; Hypertension, Malignant; Hypert | 1968 |
[Kidney and hypertension].
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Extracellular Space; Humans; Hypertension; Hyp | 1972 |
Effect of prostaglandin A 1 on renal and adrenal function in man.
Topics: Adrenal Glands; Aldosterone; Ascites; Blood Pressure; Calcium; Creatinine; Cyclic AMP; Edema; Glomer | 1972 |
[Kidney failure and internal secretion--with special reference to the renin-angiotensin-aldosterone system].
Topics: Aldosterone; Angiotensin II; Humans; Kidney Failure, Chronic; Renin | 1972 |
[Hemodialysis and hypertension].
Topics: Aldosterone; Angiotensin II; Humans; Hypertension; Kidney Failure, Chronic; Renal Dialysis; Renin | 1972 |
Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease.
Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aging; Aldoster | 1973 |
Hypertension with adrenal, genital, renal defects, and deafness. A new familial syndrome.
Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Adult; Aldosterone; Deafness; Female; Glucocort | 1973 |
Studies on the metabolism of aldosterone in chronic renal failure and anephric man.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Animals; Blood Urea Nit | 1973 |
Plasma renin and aldosterone after renal transplantation.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Blood Pressure; Body Weight | 1974 |
Plasma aldosterone during haemodialysis in patients with terminal renal failure.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Blood Pressure; Body Weight; Humans; Hydrocortisone; Hy | 1973 |
A mechanism for hyporeninemic hypoaldosteronism in chronic renal disease.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Aldosterone; Blood Pressure; Circadian Rhythm; D | 1974 |
Aldosterone response to angiotensin II in patients with terminal renal failure and after bilateral nephrectomy.
Topics: Aldosterone; Angiotensin II; Humans; Hydrocortisone; Infusions, Parenteral; Kidney; Kidney Failure, | 1974 |
Blood pressure regulation during chronic renal failure due to polycystic renal disease.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Humans; Hypertension, Renal; Kidney; K | 1974 |
Increased steroid metabolic clearance rate in anephric patients.
Topics: Adult; Aldosterone; Carbon Radioisotopes; Chromatography; Female; Hematocrit; Hemodynamics; Humans; | 1974 |
Plasma aldosterone in essential hypertension with low renin activity.
Topics: Aldosterone; Body Weight; Corticosterone; Cushing Syndrome; Furosemide; Humans; Hydrochlorothiazide; | 1974 |
[Activity of plasma renin and plasma aldosterone in terminal renal failure].
Topics: Adrenal Glands; Aldosterone; Blood Pressure; Humans; Hypertension, Renal; Kidney; Kidney Failure, Ch | 1974 |
[Hyporeninic hypoaldosteronism: pathogenetic importance of kidney parenchyma diseases and age].
Topics: Adult; Age Factors; Aged; Aldosterone; Humans; Hyperkalemia; Kidney Failure, Chronic; Middle Aged; P | 1974 |
Selective hypoaldosteronism: a case report and review of literature.
Topics: Adrenal Insufficiency; Adult; Aldosterone; Diabetes Complications; Heart Diseases; Humans; Hyperkale | 1974 |
Plasma aldosterone in patients with end stage kidney disease.
Topics: Adolescent; Adult; Aged; Aldosterone; Blood Pressure; Female; Humans; Hypertension, Renal; Kidney Fa | 1972 |
Influence of aldosterone on sodium, water and potassium metabolism in chronic renal disease.
Topics: Aldosterone; Blood; Blood Urea Nitrogen; Body Water; Creatinine; Desoxycorticosterone; Diet, Sodium- | 1972 |
Hyperkalemia in salt-wasting nephropathy. Study of the mechanism.
Topics: Aldosterone; Bicarbonates; Desoxycorticosterone; Furosemide; Glomerular Filtration Rate; Glucose; Hu | 1973 |
[Role of aldosterone in chronic kidney failure].
Topics: Aldosterone; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Natriuresis; Potassium | 1973 |
[Anephric man].
Topics: Aldosterone; Animals; Arteries; Blood Glucose; Body Weight; Diet Therapy; Dogs; Erythropoiesis; Hema | 1968 |
Hyperkalemia and coma associated with renal tubular acidosis in an old patient with refractory edema due to the nephrotic syndrome: furosemide-bicarbonate therapy.
Topics: Acidosis, Renal Tubular; Adrenal Cortex Hormones; Aged; Aldosterone; Bicarbonates; Coma; Edema; Furo | 1972 |
Studies on the mechanism of sodium excretion in uraemia.
Topics: Adult; Aldosterone; Blood Pressure; Body Weight; Creatinine; Female; Glomerular Filtration Rate; Hum | 1972 |
[Potassium metabolism in man. 1. Normal physiologic data].
Topics: Adult; Aldosterone; Diuretics; Female; Glomerular Filtration Rate; Humans; Hyperaldosteronism; Kidne | 1969 |
Selective aldosterone deficiency in chronic pyelonephritis.
Topics: Aged; Aldosterone; Blood Urea Nitrogen; Chronic Disease; Female; Fludrocortisone; Humans; Hyperkalem | 1970 |
Plasma renin activity in human hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Contraceptives, Oral; Female; Humans; Hypertension; Kidney Failu | 1970 |
Aldosterone production in chronic renal failure.
Topics: Aldosterone; Animals; Blood Urea Nitrogen; Kidney Failure, Chronic; Male; Methods; Potassium; Rats; | 1969 |
[Renal insufficiency and urinary elimination of aldosterone].
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Humans; Kidney Fail | 1963 |
[Periodic paralysis with hypokalemia: etiological and pathogenic discussion].
Topics: Adrenal Cortex Hormones; Aldosterone; Female; Humans; Hypokalemia; Kidney Failure, Chronic; Kidney F | 1965 |